非腫瘍性疾患病理アトラス　肺

出版社： 文光堂
著者：
発行日： 2022-04-15
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784830604867
電子書籍版： 2022-04-15 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

19,800 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

19,800 円(税込)

購入する

商品紹介

非腫瘍性肺疾患には，感染症，間質性肺疾患，肺高血圧症等々，多岐にわたる疾患が含まれ，肺の構成要素を複合的に侵す．複雑な病態像を示すこれらの疾患を理解するために，「肺の解剖学的・組織学的所見に照らした病変分布」を意識しながら平易に解説した．組織写真とともに，必要に応じてX線画像，肉眼写真やシェーマも用いている．また，総論では胎齢期の組織像が提示され，各論では稀な疾患を含め約70の疾患の病理像をみることができる．病理像から病因に迫るユニークな考察もある．診断に留まらない，非腫瘍性肺疾患病理アトラスの決定版．

目次

  • 第1部　総　論
    　I　呼吸器の発生
    　　1　呼吸器（肺）の発生の概要
    　　2　肺の形態形成と発育
    　　3　肺の上皮細胞の分化
    　II　呼吸器系の構造（解剖・組織）
    　　1　気道
    　　2　肺胞管（肺胞道）
    　　3　肺胞
    　　4　肺の実質と間質
    　　5　小葉と細葉
    　　6　肺の脈管系（血管，リンパ管）
    　　7　胸膜
    　III　標本の取り扱いと切り出し
    　　はじめに
    　　1　固定液
    　　2　採取方法と固定法
    　　3　肺の切り出しと写真撮影
    　IV　肺生検の見方
    　　1　肺生検標本をみるうえでの一般的な注意点
    　　2　組織標本の作製および染色
    　　3　非腫瘍性肺疾患を診断するうえでの病変の広がりの認識
    　　4　線維化病変の見方
    　　5　病変の分布および時相について
    　　6　診断におけるmultidisciplinary discussion（MDD）の重要性
    　　7　TBLCの導入
    　V　病理医にとって有用な放射線画像の情報とその見方
    　　はじめに
    　　1　CT読影の基礎
    　　2　CTの近年の進歩
    　　3　肺の構造とびまん性肺疾患の病理学的特徴
    　　4　びまん性肺疾患診断における陰影の性状と読影のポイント
    　　おわりに

    第2部　各　論
    　I．間質性肺疾患　a．特発性間質性肺炎
    　　1　特発性肺線維症/通常型間質性肺炎（IPF/UIP）
    　　2　非特異性間質性肺炎（NSIP）
    　　3　特発性器質化肺炎（COP）
    　　4　呼吸細気管支炎を伴う間質性肺疾患（RB-ILD）
    　　5　剝離性間質性肺炎（DIP）
    　　6　リンパ球性間質性肺炎（LIP）
    　　7　Pleuroparenchymal fibroelastosis（PPFE）
    　　8　急性間質性肺炎/びまん性肺胞傷害（AIP/DAD pattern）─ AFOP を含む─
    　I．間質性肺疾患　b．その他の間質性肺疾患
    　　1　膠原病関連間質性肺炎
    　　2　過敏性肺炎（HP）
    　　3　喫煙関連間質性肺炎─CPFEを含む─
    　　4　薬剤性肺炎
    　　5　好酸球性肺炎
    　　6　サルコイドーシス
    　　7　IgG4関連肺疾患
    　　8　中心性Castleman症
    　II．囊胞性肺疾患および結節性肺病変
    　　1　ブラ・ブレブ・肺気腫
    　　〔COLUMN〕一次性自然気胸の病理
    　　2　肺Langerhans細胞組織球症
    　　3　Sjögren症候群
    　　4　アミロイドーシス・軽鎖沈着症
    　　5　リンパ脈管筋腫症（LAM）
    　　6　Birt-Hogg-Dubé症候群
    　　7　胸腔子宮内膜症
    　　8　硝子化肉芽腫
    　　9　炎症性偽腫瘍
    　　〔COLUMN〕円形無気肺
    　III．気管・気管支・細気管支病変
    　　1　気管支拡張症
    　　2　気管支喘息
    　　3　閉塞性細気管支炎（BO/BBO）─濾胞性細気管支炎を含む─
    　　4　びまん性汎細気管支炎（DPB）
    　　5　再発性多発軟骨炎
    　　6　気管支結石症
    　IV．肺高血圧・血管病変
    　　1　肺動脈性肺高血圧症
    　　2　慢性血栓塞栓性肺高血圧症
    　　3　肺腫瘍血栓性微小血管症（PTTM）
    　　4　肺静脈性肺高血圧症
    　　5　肺静脈閉塞症（PVOD）
    　　6　肺血栓塞栓症および肺梗塞
    　　7　喀血
    　V．血管炎症候群
    　　1　結節性多発動脈炎（PAN）/顕微鏡的多発血管炎（MPA）
    　　2　多発血管炎性肉芽腫症
    　　3　好酸球性多発血管炎性肉芽腫症（EGPA）
    　　4　高安動脈炎（大動脈炎症候群）
    　　5　Goodpasture症候群
    　VI．職業性肺疾患
    　　1　石綿肺（アスベスト肺）
    　　2　珪　肺
    　　3　超硬合金肺
    　VII．感染症
    　　1　細菌性肺炎
    　　2　結核症および非結核性抗酸菌症
    　　3　真菌症　 a．アスペルギルス症
    　　〔COLUMN〕Charcot-Leyden結晶
    　　　　　　　　b．その他の真菌症
    　　　　　　　　c．輸入感染症
    　　〔COLUMN〕真菌のin situ hybridization法
    　　4　リケッチア感染症，ウイルス感染症
    　　5　寄生虫による肺病変
    　　6　誤嚥性肺炎
    　VIII．まれな疾患
    　　1　肺胞微石症
    　　〔COLUMN〕インジウム肺
    　　2　肺骨化症
    　　3　Hermansky-Pudlak症候群
    　　4　Erdheim-Chester病
    　　5　結合織病─Ehlers-Danlos症候群，Malfan 症候群を含む─
    　IX．移植・GVHD
    　　1　肺移植・拒絶反応
    　　2　移植片対宿主病（GVHD），特発性肺炎症候群
    　X．先天性肺疾患・小児肺疾患
    　　1　先天性肺気道奇形（CPAM）
    　　2　肺分画症/bronchopulmonary foregut malformation/気管支原性囊胞
    　　3　先天性気管支閉鎖症
    　　4　動静脈奇形

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1部 総論

P.6 掲載の参考文献
1) Cardoso WV, Lu J : Regulation of early lung morphogenesis : questions, facts and controversies. Development 133 : 1611-1624, 2006
PubMed
2) Morrisey EE, Hogan BLM : Preparing for the first breath : genetic and cellular mechanisms in lung development. Dev Cell 18 : 8-23, 2010
 
3) Langston C, Kida K, Reed M, et al : Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 129 : 607-613, 1984
PubMed
4) Lee KF, Olak J : Anatomy and physiology of the pleural space. Chest Surg Clin N Am 4 : 391-403, 1994
PubMed
P.14 掲載の参考文献
1) 岡田慶夫 : 胸の科学, 金芳堂, 1997
 
2) 山中晃, 横山武 : 肺病理アトラス, 第2版, 文光堂, 1990
 
3) 松本武四郎 : 病理学講本呼吸器, 杏林書院, 1963
 
4) 岡輝明 : 肺・非腫瘍性疾患 (肺疾患の立体的理解に向けて) I : 総論および間質性肺炎 肺構造の特徴を踏まえた呼吸器疾患の形態学的観察法. 病理と臨床 32 : 955-969, 2014
 
5) 山中晃 : 肺実質とは. 本間日臣編 : 呼吸器病学, 第3版, 医学書院, 1990, p27
 
6) 岡輝明 : 肺の疾患-非腫瘍性病変をどうみるか-I. 間質性肺炎 肺の非腫瘍性疾患の病理診断を行うための検体の取り扱いと肺構造の要点. 病理と臨床 24 : 792-800, 2006
 
7) 岡輝明 : 病理所見の解釈 (病理診断の実際). 滝澤始編 : 間質性肺炎を究める, メジカルビュー社, 2012, pp54-69
 
8) Miller WS : The lung, 2nd ed., Thomas CC, Springfield, Illinois, 1947
 
9) 松本武四郎 : 肺. 岩波講座 現代生物科学 10 組織と器官 II, 飯島宗一, 入沢宏, 岡田節人編, 岩波書店, 1977
 
10) 河西達夫 : 気管支動脈の解剖学的研究. 気管支学 11 : 530-540, 1989
 
P.19 掲載の参考文献
1) 山中晃, 横山武 : 肺病理アトラス, 文光堂, 1985, pp238-239
 
2) Kuse N, Inomata M, Awano N, et al : Management and utility of transbronchial lung cryobiopsy in Japan. Respir Investig 57 : 245-251, 2019
PubMed
3) 山中晃, 横山武 : 肺病理アトラス, 文光堂, 1985, p240
 
P.26 掲載の参考文献
1) Colby TV, Yousem SA : Pulmonary histology for the surgical pathologist. Am J Surg Pathol 12 : 223-239, 1988
PubMed
2) Romagnoli M, Colby TV, Berthet J-P, et al : Poor concordance between seqential transbronchial lung cryobopsy and surgical lung biopsy in the diagnosis of diffuse interstitial lung diseases. Am J Respir Crit Care Med 199 : 1249-1256, 2019
 
P.36 掲載の参考文献
1) 松本武四郎 : 第10章 肺. 飯島宗一, 入沢宏, 岡田節人編 : 岩波講座 現代生物科学 組織と器官, 岩波書店, 1977, pp315-372
 
2) 伊藤春海, 村田喜代史 : 間質性肺疾患の画像診断 ; 基礎 ; 肺小葉から細葉へ. 日本胸部臨床 72 : S100-S109, 2013
 
3) 岡輝明 : 肺構造の特徴を踏まえた呼吸器疾患の観察 肺非腫瘍性疾患. 病理と臨床 32 : 955-969, 2014
 
4) 野間恵之 : 蜂巣肺と牽引性気管支拡張の画像-病理相関および鑑別 : 3次元表示などの有用性. 酒井文和, 上甲剛, 野間恵之編 : 特発性肺線維症の画像診断 蜂巣肺, IPF/UIP画像診断の理解のために, メディカル・サイエンス・インターナショナル, 2015
 
5) 徳田均 : 肺結核の画像所見 : 細葉性病変とその諸相. 結核 84 : 551-557, 2009
 
6) Yanagawa M, Tsubamoto M, Satoh Y, et al : Lung adenocarcinoma at CT with 0.25-mm section thickness and a 2048 matrix : High-spatial-resolution imaging for predicting invasiveness. Radiology 297 : 462-471, 2020
 
7) 武村民子 : 慢性線化性間質性肺炎と蜂巣肺の病理. 酒井文和, 上甲剛, 野間恵之編 : 特発性肺線維症の画像診断 蜂巣肺, IPF/UIP画像診断の理解のために, メディカル・サイエンス・インターナショナル, 2015, pp25-56
 
8) Raghu G, Remy-Jardin M, Myers JL, et al : Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198 : e44-e68, 2018
PubMed
9) Watadani T, Sakai F, Johkoh T, et al : Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 266 : 936-944, 2013
PubMed
10) 野間恵之 : 蜂巣肺と牽引性気管支拡張の画像-病理相関および鑑別. 酒井文和, 上甲剛, 野間恵之編 : 特発性肺線維症の画像診断 蜂巣肺, IPF/UIP画像診断の理解のために, メディカル・サイエンス・インターナショナル, 2015, pp77-96
 
11) Frazier AA, Franks TJ, Mohammed TLH, et al : From the archives of the AFIP pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics 27 : 867-882, 2007
 
12) Im JG, Itoh H, Shim YS, et al : Pulmonary tuberculosis : CT indings-early active disease and sequential change with antituberculous therapy. Radiology 186 : 653-660, 1993
 

第2部 各論

P.45 掲載の参考文献
1) Liebow AA, Carrington CB : The interstitial pneumonias. in Simon M, Potchen EJ, LeMay M (eds) : Frontiers of Pulmonary Radiology, Grune & Stratton, New York, 1969, pp102-141
 
2) Basset F, Ferrans VJ, Soler P, et al : Intraluminal fibrosis in interstitial lung disorder. Am J Pathol 122 : 443-461, 1986
PubMed
3) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : update of international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
4) American Thoracic Society, European Respiratory Society : American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002
PubMed
5) Raghu G, Collard HR, Egan JJ, et al : An official ATS/ERS/JRS/ALAT statement : Idiopathic pulmonary fibrosis : evidence-based guidelines of diagnosis and management. Am J Respir Crit Care Med 183 : 788-824, 2011
PubMed
6) Raghu G, Jardin MR, Meyers JL, et al : Diagnosis of idiopathic pulmonary fibrosis : An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198 : e44-e68, 2018
 
7) Katzenstein ALA : Idiopathic interstitial pneumonia. Surgical Pathology of Non-neoplastic Lung Diseases (4th ed), Saunders Elsevier, Philadelphia, 2006, pp51-84
 
8) Yamauchi H, Bando M, Baba T, et al : Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing. PLoS One 11 : e0166168, 2016
PubMed
P.52 掲載の参考文献
1) American Thoracic Society/European Respiratory Society : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002
PubMed
2) Katzenstein AL, Fiorelli RF : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18 : 136-147, 1994
PubMed
3) Travis WD, Hunninghake G, King TE Jr, et al : Idiopathic nonspecific interstitial pneumonia : report of an American Thoracic Society project. Am J Respir Crit Care Med 177 : 1338-1347, 2008
PubMed
4) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
5) Park IN, Jegal Y, Kim DS, et al : Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J 33 : 68-76, 2009
PubMed
6) Kono M, Nakamura Y, Yoshimura K, et al : Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease. Respir Med 117 : 40-47, 2016
PubMed
7) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会編 : 特発性間質性肺炎 診断と治療の手引き, 改訂第3版, 南江堂, 2016, ix, p156
 
8) Fischer A, Antoniou KM, Brown KK, et al : An official European Respiratory Society/American Thoracic Society research statement : interstitial pneumonia with autoimmune features. Eur Respir J 46 : 976-987, 2015
PubMed
9) Brown KK, Martinez FJ, Walsh SLF, et al : The natural history of progressive fibrosing interstitial lung diseases. Eur Respir J 55 : 2000085, 2020
PubMed
10) Raghu G, Remy-Jardin M, Myers JL, et al : Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198 : e44-e68, 2018
PubMed
11) Kambouchner M, Levy P, Nicholson AG, et al : Prognostic relevance of histological variants in nonspecific interstitial pneumonia. Histopathology 65 : 549-560, 2014
PubMed
12) Flaherty KR, Toews GB, Travis WD, et al : Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J 19 : 275-283, 2002
 
13) Monaghan H, Wells AU, Colby TV, et al : Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 125 : 522-526, 2004
PubMed
14) Hashisako M, Tanaka T, Terasaki Y, et al : Interobserver agreement of usual interstitial pneumonia diagnosis correlated with patient outcome. Arch Pathol Lab Med 140 : 1375-1382, 2016
PubMed
15) Miyamoto A, Sharma A, Nishino M, et al : Expanded acceptance of acute exacerbation of nonspecific interstitial pneumonia, including 7 additional cases with detailed clinical pathologic correlation. Pathol Int 68 : 401-408, 2018
PubMed
P.57 掲載の参考文献
1) Davison AG, Heard BE, McAllister, WA, et al : Cryptogenic organizing pneumonitis. Q J Med 52 : 382-394, 1983
PubMed
2) Epler GR, Colby TV, McLoud TC, et al : Bronchiolitis obliterans organizing pneumonia. N Engl J Med 312 : 152-158, 1985
PubMed
3) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
4) Cordier JF : Cryptogenic organising pneumonia. Eur Respir J 28 : 422-446, 2006
PubMed
5) Nagai S, Aung H, Tanaka S, et al : Bronchoalveolar lavage cell findings in patients with BOOP and related diseases. Chest 102 : 32S-37S, 1992
PubMed
6) Mehrjardi ZM, Kahkouee S, Pourabdollah M : Radiopathological correlation of organizing pneumonia (OP) : a pictorial review. Br J Radiol 90 : 20160723, 2017
 
7) Colby TV : Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 102 : 38S-43S, 1992
PubMed
8) Fukuda Y, Ishizaki M, Kudoh S, et al : Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab Invest 78 : 687-698, 1998
PubMed
9) Takato H, Waseda Y, Watanabe S, et al : Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM. Respir Med 107 : 128-133, 2013
PubMed
10) Lazor R, Vandevenne A, Pelletier A, et al : Cryptogenic organizing pneumonia. Characteristics of relapses in a series of 48 patients. The Groupe d'Etudes et de Recherche sur les Maladles "Orphelines" Pulmonaires (GERM"O"P). Am J Respir Crit Care Med 162 : 571-577, 2000
 
P.64 掲載の参考文献
1) Niewoehner DE, Kleinerman J, Rice DB : Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 291 : 755-758, 1974
PubMed
2) Myers JL, Veal CF Jr, Shin MS, et al : Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 135 : 880-884, 1987
PubMed
3) Yousem SA, Colby TV, Gaensler EA : Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 64 : 1373-1380, 1989
PubMed
4) American Thoracic Society/European Respiratory Society : American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002
PubMed
5) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
6) Kawabata Y, Hoshi E, Murai M, et al : Smoking-related changes in the background lung of specimens resected for lung cancer : a semiquantitative study with correlation to post operative course. Histopathology 53 : 707-714, 2008
 
7) Park JS, Brown KK, Tuder RM, et al : Respiratory bronchiolitis-associated interstitial lung disease : Radiologic features with clinical and pathologic correlation. J Comput Assist Tomogr 26 : 13-20, 2002
PubMed
8) Nakanishi M, Demura Y, Mizuno S, et al : Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation. Eur Respir J 29 : 453-461, 2007
PubMed
9) Portnoy J, Veraldi KL, Schwarz MI, et al : Respiratory bronchiolitis-interstitial lung disease : long-term outcome. Chest 131 : 664-671, 2007
PubMed
10) Fraig M, Shreesha U, Savici D, et al : Respiratory bronchiolitis : a clinic-pathologic study in current smokers, ex-smokers, and never- smokers. Am J Surg Pathol 26 : 647-653, 2002
 
11) Scheidl SJ, Kusej M, Flick H, et al : Clinical manifestations of respiratory bronchiolitis as an incidental finding in surgical lung biopsies : A retrospective analysis of a large Austrian registry. Respiration 91 : 26-33, 2016
PubMed
12) Guo B, Wang L, Xia S, et al : The interstitial lung disease spectrum under a uniform diagnostic algorithm : a retrospective study of 1,945 individuals. J Thorac Dis 12 : 3688-3696, 2020
 
13) Kumar A, Cherian SV, Vassallo R, et al : Current concepts in pathogenesis, diagnosis, and management of smokingrelated interstitial lung diseases. Chest 154 : 394-408, 2018
 
14) Ryu JH, Colby TV, Hartman TE, et al : Smoking-related interstitial lung diseases : a concise review. Eur Respir J 17 : 122-132, 2001
PubMed
15) Margaritopoulos GA, Harari S, Caminati A, et al : Smokingrelated idiopathic interstitial pneumonia : A review. Respirology 21 : 57-64, 2016
 
16) Hellemons ME, Moor CC, von der Thusen J, et al : Desquamative interstitial pneumonia : a systematic review of its features and outcomes. Eur Respir Rev 29 : 190181, 2020
PubMed
17) 河端美則 : 喫煙関連間質性肺疾患-概説と病態. 永井厚志他編 : Annual Review 呼吸器 2013, 中外医学社, 2013, pp98-104
 
18) 河端美則 : Smoker's respiratory bronchiolitis. 病理と臨床 20 : 940-943, 2002
Medical*Online
19) Fukuoka J, Franks TJ, Colby TV, et al : Peribronchiolar metaplasia : a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease : clinicopathologic features of 15 cases. Am J Surg Pathol 29 : 948-954, 2005
 
20) Kuranishi LT, Leslie KO, Ferreira RG, et al : Airwaycentered interstitial fibrosis : etiology, clinical findings and prognosis. Respir Res 16 : 55, 2015
PubMed
21) 河端美則 : 剥離性間質性肺炎・呼吸細気管支炎を伴う間質性肺疾患の病理. 病理と臨床 24 : 843-850, 2006
Medical*Online
22) Yamada T, Nakanishi Y, Homma T, et al : Airspace enlargement with fibrosis shows characteristic histology and immunohistology different from usual interstitial pneumonia, nonspecific interstitial pneumonia, and centrilobular emphysema. Pathol International 63 : 206-213, 2013
 
23) Watanabe Y, Kawabata Y, Kanauchi T, et al : Multiple, thinwalled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol 84 : 986-992, 2015
 
24) Yousem SA. Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia : a proposal. Mod Pathol 19 : 1474-1479, 2006
 
25) Katzenstein AL, Mukhopadhyay S, Zanardi C, et al : Clinically occult interstitial fibrosis in smokers : classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 41 : 316-325, 2010
PubMed
26) Reddy TL, Mayo J, Churg A : Respiratory bronchiolitis with fibrosis : highresolution computed tomography findings and correlation with pathology. Ann Am Thorac Soc 10 : 590-601, 2013
 
27) Otani H, Tanaka T, Fukuoka J, et al : Smoking-related interstitial fibrosis combined with pulmonary emphysema : computed tomography-pathologic correlative study using lobectomy specimens. Int J Chron Obstruct Pulmon Dis 11 : 1521-1532, 2016
PubMed
28) Flower M, Nandakumar L, Singh M, et al : Respiratory bronchiolitis-associated interstitial lung disease secondary to electronic nicotine delivery system use confirmed with open lung biopsy. Respirol Case Rep 5 : e00230, 2017
PubMed
P.70 掲載の参考文献
1) Liebow AA, Steer A, Billingsley JG : Desquamative interstitial pneumonia. Am J Med 39 : 369-404, 1965
PubMed
2) Carrington CB, Gaensler EA, Coutu RE : Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298 : 801-809, 1978
PubMed
3) American Thoracic Society, European Respiratory Society : American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002
PubMed
4) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
5) Kawabata Y, Takemura T, Hebisawa A, et al : Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically. Respirology 17 : 1214-1221, 2012
PubMed
6) Kawabata Y, Takemura T, Hebisawa A, et al : Increased eosinophils in bronchoalveolar lavage fluid and lobule-based histologic lesions Are characteristic features of desquamative interstitial pneumonia. Histopathology 52 : 194-202, 2008
 
7) Hellemons ME, Moor CC, von der Thusen J, et al : Desquamative interstitial pneumonia : a systematic review of its features and outcomes. Eur Respir Rev 29 : 190181, 2020
PubMed
8) Akira M, Yamamoto S, Hara H, et al : Serial computed tomographic evaluation in desquamative interstitial pneumonia. Thorax 52 : 333-337, 1997
PubMed
9) 河端美則 : 剥離性間質性肺炎. 工藤翔二他編 : Annual Review 呼吸器 2000, 中外医学社, 2000, pp138-143
 
10) Kawabata Y, Takemura T, Hebisawa A, et al : Desquamative interstitial pneumonia may progress to lung fibrosis as characterized radiologically. Respirology 17 : 1214-1221, 2012
PubMed
11) 河端美則 : 剥離性間質性肺炎. 病理と臨床 24 : 843-850, 2006
Medical*Online
12) Hartman TE, Primack SL, Swensen SJ, et al : Desquamative interstitial pneumonia : thin-section CT findings in 22 patients. Radiology 187 : 787-790, 1993
PubMed
13) Kumar A, Cherian SV, Vassallo R, et al : Current concepts in pathogenesis, diagnosis, and management of smokingrelated interstitial lung diseases. Chest 154 : 394-408, 2018
 
14) 河端美則 : 喫煙関連間質性肺疾患-概説と病態. 永井厚志他編 : Annual Review 呼吸器 2013, 中外医学社, 2013, pp98-104
 
15) 河端美則 : Smoker's respiratory bronchiolitis. 病理と臨床 20 : 940-943, 2002
Medical*Online
16) 松島秀和, 高柳昇, 坂本龍彦他 : 治療前と治療2カ月後の組織所見が得られた剥離性間質性肺炎の1例. 日呼吸会誌 39 : 609-614, 2001
 
17) Hansell DM, Nicholson AG : Smoking-related diffuse parenchymal lung disease : HRCT-pathologic correlation. Semin Respir Crit Care Med 24 : 377-392, 2003
PubMed
18) Tazelaar HD, Wright JL, Churg A : Desquamative interstitial pneumonia. Histopathology 58 : 509-516, 2011
PubMed
P.75 掲載の参考文献
1) Liebow AA, Carrington CB : Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 57 : 809-843, 1973
PubMed
2) American Thoracic Society, European Respiratory Society : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165 : 277-304, 2002
 
3) Nicholson AG : Lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung. Semin Respir Crit Care Med 22 : 409-422, 2001
PubMed
4) Restrepo CS, Carrillo J, de Christensen MR, et al : Lymphoproliferative lung disorders : a radiologic-pathologic overview. Part II : Neoplastic disorders. Semin Ultrasound CT MR 34 : 535-549, 2013
 
5) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
6) Strimlan CV, Rosenow EC 3rd, Weiland LH, et al : Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 88 : 616-621, 1978
PubMed
7) Koss MN, Hochholzer L, Langloss JM, et al : Lymphoid interstitial pneumonia : clinicopathological and immunopathological findings in 18 cases. Pathology 19 : 178-185, 1987
 
8) Cha SI, Fessler MB, Cool CD, et al : Lymphoid interstitial pneumonia : clinical features, associations and prognosis. Eur Respir J 28 : 364-369, 2006
PubMed
9) Honda O, Johkoh T, Ichikado K, et al : Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 173 : 71-74, 1999
PubMed
10) Johkoh T, Muller NL, Pickfold HA, et al : Lymphocytic interstitial pneumonia : thin-section CT findings in 22 patients. Radiology 212 : 567-572, 1999
 
11) Ichikawa Y, Kinoshita M, Koga T, et al : Lung cyst formation in lymphocytic interstitial pneumonia : CT features. J Comput Assist Tomogr 18 : 745-748, 1994
PubMed
12) Nicholson AG, Wotherspoon AC, Diss TC, et al : Reactive pulmonary lymphoid disorders. Histopathology 26 : 405-412, 1995
PubMed
P.79 掲載の参考文献
1) 渡辺憲太朗 : 上葉優位型肺線維症 (PPFE) の病態と治療戦略. 呼吸器ジャーナル 66 : 302-311, 2018
 
2) Frankel SK, Cool CD, Lynch DA, et al : Idiopathic pleuroparenchymal fibroelastosis : description of a novel clinicopathologic entity. Chest 126 : 2007-2013, 2004
PubMed
3) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
4) 網谷良一, 新実彰男, 久世文幸 : 特発性上葉限局型肺線維症. 呼吸 11 : 693-699, 1992
Medical*Online
5) 久保武 : びまん性肺疾患の画像診断 : PPFE. 日本胸部臨床 75 : 1276-1283, 2016
 
6) Takeuchi Y, Miyagawa-Hayashino A, Chen F, et al : Pleuroparenchymal fibroelastosis and non-specific interstitial pneumonia : frequent pulmonary sequelae of haematopoietic stem cell transplantation. Histopathology 66 : 536-544, 2015
PubMed
7) Ofek E, Sato M, Saito T, et al : Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol 26 : 350-356, 2013
PubMed
8) 渡辺憲太朗 : PPFEと特発性肺線維症. 最新医学 71 : 1306-1313, 2016
Medical*Online
9) von der Thusen JH, Hansell DM, Tominaga M, et al : Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol 24 : 1633-1639, 2011
PubMed
10) Terasaki Y, Kajimoto Y, Okabe Y, et al : Pathological features of lung lesions in PPFE of idiopathic or transplantation related cases with evaluation of the elastic fiber related conditions comparing to those of IPF/UIP. Eur Respir J 54 : 10.1183/13993003.congress-2019.OA247, 2019
 
11) Hirota T, Yoshida Y, Kitasato Y, et al : Histological evolution of pleuroparenchymal fibroelastosis. Histopathology 66 : 545-554, 2015
PubMed
12) Camus P, von der Thusen J, Hansell DM, et al : Pleuroparenchymal fibroelastosis : one more walk on the wild side of drugs? Eur Respir J 44 : 289-296, 2014
PubMed
13) Reddy TL, Tominaga M, Hansell DM, et al : Pleuroparenchymal fibroelastosis : a spectrum of histopathological and imaging phenotypes. Eur Respir J 40 : 377-385, 2012
PubMed
14) Watanabe K : Pleuroparenchymal fibroelastosis : Its clinical characteristics. Curr Respir Med Rev 9 : 299-237, 2013
PubMed
15) Harada T, Yoshida Y, Kitasato Y, et al : The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis. Eur Respir Rev 23 : 263-266, 2014
PubMed
16) Yoshida Y, Nagata N, Tsuruta N, et al : Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis. Respir Investig 54 : 162-169, 2016
PubMed
17) Watanabe K, Nagata N, Kitasato Y, et al : Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig 50 : 88-97, 2012
PubMed
18) Chua F, Desai SR, Nicholson AG, et al : Pleuroparenchymal fibroelastosis. A review of clinical, radiological, and pathological characteristics. Ann Am Thorac Soc 16 : 1351-1359, 2019
PubMed
19) McLoud TC, Isler RJ, Novelline RA, et al : The apical cap. AJR Am J Roentgenol 137 : 299-306, 1981
PubMed
20) Ishii H, Watanabe K, Kushima H, et al : Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan. Respir Med 141 : 190-197, 2018
PubMed
21) Watanabe K, Ishii H, Kiyomi F, Terasaki Y, et al : Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis : A proposal. Respir Investig 57 : 312-320, 2019
 
P.86 掲載の参考文献
1) American Thoracic Society, European Respiratory Society : American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 165 : 277-304, 2002
PubMed
2) Katzenstein AL, Myers JL, Mazur MT : Acute interstitial pneumonia. A clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 10 : 256-267, 1986
PubMed
3) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
4) Ware LB, Matthay MA : The acute respiratory distress syndrome. N Engl J Med 342 : 1334-1349, 2000
PubMed
5) ARDS Definition Task Force : Acute respiratory distress syndrome : the Berlin Definition. JAMA 307 : 2526-2533, 2012
PubMed
6) Thille AW, Esteban A, Fernandez-Segoviano P, et al : Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy. Am J Respir Crit Care Med 187 : 761-767, 2013
PubMed
7) Sarmiento X, Guardiola JJ, Almirall J, et al : Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage. Respir Med 105 : 1170-1175, 2011
PubMed
8) Katzenstein AL, Fiorelli RF : Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18 : 136-147, 1994
PubMed
9) Beasley MB, Franks TJ, Galvin JR, et al : Acute fibrinous and organizing pneumonia : a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 126 : 1064-1070, 2002
PubMed
10) Feng A-N, Cai H-R, Zhou Q, et al : Diagnostic problems related to acute fibrinous and organizing pneumonia : misdiagnosis in 2 cases of lung consolidation and occupying lesions. Int J Clin Exp Pathol 7 : 4493-4497, 2014
PubMed
11) Nishino M, Mathai SK, Schoenfeld D, et al : Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia. Hum Pathol 45 : 342-351, 2014
PubMed
P.95 掲載の参考文献
1) 日本呼吸器学会・日本リウマチ学会合同膠原病に伴う間質性肺疾患 診断・治療指針作成委員会編 : 膠原病に伴う間質性肺疾患 診断・治療指針 2020, メディカルレビュー社, 2020
 
2) Travis WD, Colby TV, Koss MN, et al : Non-neoplastic disorders of the lower respiratory tract (Atlas of nontumor pathology), American Registry of Pathology, Washington DC, 2002
 
3) 武村民子 : リウマチ性疾患における間質性肺病変の病理. リウマチ科 49 : 152-160, 2013
 
4) 藤田次郎, 小倉高志, 高橋弘毅他 : 膠原病に合併した間質性肺炎 (座談会). 呼吸 27 : 1123-1137, 2008
 
5) Gono T, Tokuda H, Sakai F, et al (eds) : Lung Disease Associated with Rheumatoid Arthritis (1st ed), Springer Nature Singapore Pte Ltd, 2018
 
6) Lee HK, Kim DS, Yoo B, et al : Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127 : 2019-2027, 2005
PubMed
7) Park IN, Kim DS, Shim TS, et al : Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 132 : 214-220, 2007
PubMed
8) Douglas WW, Tazelaar HD, Hartman TE, et al : Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 164 : 1182-1185, 2001
PubMed
9) Watanabe K, Handa T, Tanizawa K, et al : Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias. Respir Med 105 : 1238-1247, 2011
PubMed
10) Takato H, Waseda Y, Watanabe S, et al : Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia-with or without PM/DM. Respir Med 107 : 128-133, 2013
PubMed
11) Yousem SA, Schneider F, Bi D, et al : The pulmonary histopathologic manifestations of the anti-PL7/antithreonyl transfer RNA synthetase syndrome. Hum Pathol 45 : 1199-1204, 2014
PubMed
12) Homma S, Suzuki A, Sato K : Pulmonary involvement in ANCA-associated vasculitis from the view of the pulmonologist. Clin Exp Nephrol 17 : 667-671, 2013
PubMed
13) 小倉高志, 蛇澤晶 : ANCA関連間質性肺炎. 日本胸部臨床 72 : S248-S255, 2013
Medical*Online
P.103 掲載の参考文献
1) Fernandez Perez ER, Kong AM, Raimundo K, et al : Epidemiology of hypersensitivity pneumonitis among an insured population in the united states : A claims-based cohort analysis. Ann Am Thorac Soc 15 : 460-469, 2018
PubMed
2) 吉澤靖之 : 過敏性肺炎. 日本胸部臨床 75 : 2-18, 2016
Medical*Online
3) Yoshizawa Y, Ohtani Y, Hayakawa H, et al : Chronic hypersensitivity pneumonitis in Japan : a nationwide epidemiologic survey. J Allergy Clin Immunol 103 : 315-320, 1999
PubMed
4) Lacasse Y, Selman M, Costabel, et al : Classification of hypersensitivity pneumonitis : a hypothesis. Int Arch Allergy Immunol 149 : 161-166, 2009
PubMed
5) Ohtani Y, Saiki S, Sumi Y, et al : Clinical features of recurrent and insidious chronic bird fancier's lung. Ann Allergy Asthma Immunol 90 : 604-610, 2003
PubMed
6) Ando M, Arima K, Yoneda R, et al : Japanese summer0type hypersensitivity pnuemonitis. Geographic distribution, home environment, and clinical characteristics of 621 cases. Am Rev Respir Dis 144 : 765-769, 1991
 
7) Okamoto T, Miyazaki Y, Ogura T, et al : A nationawide epidemiological survey of chronic hypersensitivity pnuemonitis in Japan. Respir Invest 51 : 191-199, 2013
 
8) Vasakova M, Morell F, Walsh S, et al : Hypersensitivity pneumonitis : Perspectives in diagnosis and management. Am J Respir Crit Care Med 196 : 680-689, 2017
PubMed
9) Salisbury ML, Myers JL, Belloi EA, et al : Diagnosis and treatment fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. Am J Resir Crit care Med 196 : 690-699, 2017
 
10) Morisset J, Johannson KA, Jones KD, et al : Identification of diagnostic criteria fro chronic hypersensitivity pneumonitis. An international modified Delphi survey. Am J Respir Crit Care Med 197 : 1038-1044, 2018
 
11) Raghu G, Remy-Jardin M, Ryerson CJ, et al : Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 202 : e36-e69, 2020
PubMed
12) Mitaka K, Miyazaki Y, Yasui M, et al : Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis. Int Arch Allergy Immunol 154 : 264-274, 2011
 
13) Fernandez Perez ER, Travis WD, Lynch DA, et al : Diagnosis and evaluation of hypersensitivity pneumonitis : Chest guideline and expert panel reports-executive summary. Chest pre-proof. https://doi.org/10.1016/j.chest.2021.03.067.
 
14) Fukuoka J, Franks TJ, Colby TV, et al : Peribronchiolar metaplasia : a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease : clinicopathologic features of 15 cases. Am J Surg Pathol 29 : 948-954, 2005
 
15) Takemura T, Akashi T, Kamiya H, et al : Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 61 : 1026-1035, 2012
PubMed
16) Chiba S, Tsuchiya K, Akashi T, et al : Chronic hypersensitivity pneumonitis with a usual interstitial pneumonia-like pattern : correlation between histopathologic and clinical findings. Chest 149 : 1473-1481, 2016
PubMed
17) Akashi T, Takemura T, Ando N, et al : Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am J Clin Pathol 131 : 405-415, 2009
PubMed
18) Khoor A, Leslie KO, Tazelaar HD, et al : Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol 115 : 755-762, 2001
PubMed
19) Lederer DJ, Martinez FJ : Idiopathic pulmonary fibrosis. N Engl J Med 378 : 1811-1823, 2018
PubMed
20) Travis WD, Costabel U, Hansell DM, et al : An official American Thoracic Society/European Respiratory Society statement : update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188 : 733-748, 2013
PubMed
21) Raghu G, Remy-Jardin M, Myers JL, et al : Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Res Crit Care Med 198 : e44-e68, 2018
 
22) Raghu G, Collard HR, Egan JJ, et al : An official ATS/ERS/JRS/ALAT statement : Idiopathic pulmonary fibrosis : Evidnece-based guidelines for diagnosis and management. Am J Resp Crit Care Med 183 : 788-824, 2011
 
23) Morell F, Villar A, Montero MA, et al : Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis : a prospective case-cohort study. Lancet Respir Med 1 : 685-694, 2013
 
24) Fernandez Perez ER, Swigris JJ, Forsson AV, et al : Identifying antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis. Chest 144 : 1644-1651, 2013
 
25) Churg A, Sin DD, Everett D, et al : Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol 33 : 1765-1770, 2009
PubMed
26) Gaxiola M, Buendia-Roldan I, Mejia M, et al : Morphologic diversity of chronic pigeon breeder's disease : Clinical features and survival. Resp Med 105 : 608-614, 2011
 
27) Churg A, Wright JL, Ryerson CJ : Pathologic separation of chronic hypersensitivity pneumonitis from fibrotic connective tissue disease-associated interstitial lung disease. Am J Surg Pathol 41 : 1403-1409, 2017
PubMed
28) Wright JL, Churg A, Hague CJ, et al : Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis. Mod Pathol 33 : 616-625, 2020
PubMed
P.107 掲載の参考文献
1) Wiggins J, Strickland B, Turner-Warwick M : Combined cryptogenic fibrosing alveolitis and emphysema : the value of high resolution computed tomography in assesement. Respir Med 84 : 365-369, 1990
 
2) Hiwatari N, Shimura S, Takishima T : Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause. Respiration 60 : 354-358, 1993
PubMed
3) Cottin V, Nunes H, Brillet P-Y, et al : Combined pulmonary fibrosis and emphysema. A distinct underrecognised entity. Eur Respir J 26 : 586-593, 2005
PubMed
4) Cottin V, Le Pavec J, Prevot G, et al : Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 35 : 105-111, 2010
PubMed
5) Cottin V Nunes H, Mouthon L, et al : Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 63 : 295-304, 2011
PubMed
6) Mejia M, Carrillo G, Rojas-Serano J, et al : Idiopathic pulmonary fibrosis and emphysema : Decreased survival associated with severe pulmonary arterial hypertension. Chest 136 : 10-15, 2009
 
7) Kitaguchi Y, Fujimoto K, Hanaoka M, et al : Clinical Characteritics of combined pulmonary fibrosis and emphysema. Respirology 15 : 265-271, 2010
 
8) Usui K, Tanai C, Tanaka Y, et al : The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 16 : 326-331, 2011
PubMed
9) Sugino K, Ishida F, Kikuchi N, et al : Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone. Respirology 19 : 239-246, 2014
 
10) 伊藤貴文, 杉野圭史, 坂本晋他 : 気腫合併特発性肺線維症の臨床病理学的特徴. 日呼吸誌 1 : 182-189, 2012
 
11) Kurashima K, Takayanagi N, Tsuchiya N, et al : The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 15 : 843-848, 2010
PubMed
12) Sakai F, Tominaga J, Kaga A, et al : Imaging diagnosis of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema). Pulm Med 2012 : 816541, 2012
PubMed
13) Iwasawa T, Takemura T, Ogura T : Smoking-related lung abnormalities on computed tomography images ; comparison with pathological findings. Jap J Radiology 36 : 165-180, 2018
 
14) Inomata M, Ikushima S, Awano N, et al : An autopsy study of combined pulmonary fibrosis and emphysema : correlations among clinical, radiological, and pathological features. BMC Pulm Med 14 : 104, 2014
PubMed
15) Wright JL, Tazelaar HD, Churg A : Fibrosis with emphysema. Histopathology 18 : 517-524, 2011
 
16) Yousem SA : Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia : a proposal. Mod Pathol 19 : 1474-1479, 2006
 
17) Kawabata Y, Hoshi E, Murai K, et al : Smoking-related changes in the background lung of specimens resected for lung cancer : a semiquantitative study with correlation to postoperative course. Histopathology 53 : 707-714, 2008
PubMed
18) Katzenstein A-L A, Mukhopadhyay S, Zanardi C, et al : Clinically occult interstitial fibrosis in smokers : classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 41 : 316-325, 2010
PubMed
19) Katzenstein ALA : Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP9, and transbronchial biopsy in UIP. Mod Pathol 25 : S68-78, 2012
 
20) Awano N, Inomata M, Ikushima S, et al : Histological analysis of vasculopathy associated with pulmonary hypertension in combined pulmonary fibrosis and emphysema : comparison with idiopathic pulmonary fibrosis or emphysema alone. Histopathology 70 : 896-905, 2017
PubMed
21) Hueper K, Vogel-Claussen J, Parikh MA, et al : Pulmonary microvascular blood Flow in mild chronic obstructive pulmonary disease and emphysema. The MESA COPD study. Am J Respir Crit Care Med 192 : 570-580, 2015
PubMed
22) Adler JK, Guo N, Kembou F, et al : Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med 184 : 904-912, 2011
 
23) Hatabu H, Hunninghake GM, Richeldi L, et al : Interstitial lung abnormalities detected incidentally on CT : a position paper from the Fleischner Society. Lancet Respir Med 8 : 726-737, 2020
 
P.115 掲載の参考文献
1) Camus P, Fanton A, Bonniaud P, et al : Interstitial lung disease induced by drugs and radiation. Respiration 71 : 301-326, 2004
PubMed
2) 日本呼吸器学会薬剤性肺障害の診断・治療の手引き第2版作成委員会編 : 薬剤性肺障害の診断・治療の手引き, 第2版, メディカルレビュー社, 2018, pp1-46
 
3) Camus P, Rosenow ECIII : Iatrogenic lung disease. Clin Chest Med 25 : xiii-xix, 2004
 
4) Camus P, Bonniaud P, Fanton A, et al : Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med 25 : 479-519, 2004
PubMed
5) Meyers JL, El-Zammar O : Pathology of drug-induced lung disease. in Katzenstein (ed) : Katzenstein and Askin's Surgical Pathology of Non-neoplastic Lung Disease (4th ed), Philadelphia, 2006, pp85-126
 
6) Patton K, Borchoff DC : Adverse drug reactions. Anaesthesia 73 (Suppl 1) : 76-84, 2018
 
7) Demoly P, Adkinson NF, Brockow K, et al : International consensus on drug allergy. Allergy 69 : 420-437, 2014
PubMed
8) Matsuno O : Drug-induced interstitial lung disease : mechanisms and best diagnostic approaches. Respir Res 13 : 39, 2012
PubMed
9) Knowles SR, Uetrecht J, Shear N : Idiosyncratic drug reactions : the reactive metabolite syndromes. Lanacet 356 : 1587-1591, 2000
PubMed
10) Maldonado F, Limper AH : Drug-induced pulmonary disease. in Mason RJ, Broaddus VC, Martin TR, et al (eds) : Textbook of Respiratory Medicine (5th ed), Vol II, Philadelphia, Saunders, 2010, pp1691-1718
 
11) Delaunois LM : Mechanisms inpulmonary toxicology. Clin Chest Med 25 : 1-14, 2004
 
12) Gruchalla RS : Drug metabolism, dander signals, and druginduced hypersensitivity. J Allergy Clin Immunol 108 : 475-488, 2001
 
13) 福田悠 : II. 疾患の病院と病態 9. ゲフィチニブと肺病変-病理学の立場から. 工藤翔二, 土屋了介, 金沢実他編 : Annual Review 呼吸器 2004, 中外医学社, 2004, pp130-136
 
14) Valid B, Marik PE : Pulmonary complications of novel antineoplastic agents for solid tumors. Chest 133 : 528-538, 2008
 
15) 高橋美紀子, 功刀しのぶ, 寺崎康弘他 : エルロチニブによる薬剤性肺障害が疑われた1剖検例. 診断病理 27 : 343-346, 2010
 
16) Ohmori T, Tamaoka T, Ando K, et al : Molecular and clinical features of EGFR-TKI-associated lung injury. Int J Mo Sci 22 : 792, 2021
 
17) Naidoo J, Page DB, Li BT, et al : Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 26 : 2375-2391, 2015
PubMed
18) Nishino M, Ramaiya KH, Awad MM, et al : PD-1 inhibitorrelated pneumonitis in advanced cancer patients : radiographic patterns and clinical course. Clin Cancer Res 22 : 6051-6060, 2016
 
19) Naidoo J, Wang X, Woo KW, et al : Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy. J Clin Oncol 35 : 709-717, 2017
 
P.120 掲載の参考文献
1) Reeder WH, Goodrich BE : Pulmonary infiltration with eosinophilia (PIE syndrome). Ann Intern Med 36 : 1217-1240, 1952
PubMed
2) Crofton JW, Livingstone JL, Oswald NC, et al : Pulmonary eosinophilia. Thorax 7 : 1-35, 1952
PubMed
3) Citro LA, Gordon ME, Miller WT : Eosinophilic lung disease (or how to slice P.I.E.). Am J Roentgenol Radium Ther Nucl Med 117 : 787-797, 1973
PubMed
4) Liebow AA, Carrington CB : The eosinophilic pneumonias. Medicine (Baltimore) 48 : 251-285, 1969
PubMed
5) Allen J, Wert M : Eosinophilic Pneumonias. J Allergy Clin Immunol Pract 6 : 1455-1461, 2018
PubMed
6) Allen JN, Pacht ER, Gadek JE, et al : Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med 321 : 569-574, 1989
PubMed
7) Allen JN, Davis WB : Eosinophilic lung diseases. Am J Respir Crit Care Med 150 : 1423-1438, 1994
 
8) Pope-Harman AL, Davis WB, Allen ED, et al : Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 75 : 334-342, 1996
PubMed
9) Suzuki Y, Suda T : Eosinophilic pneumonia : A review of the previous literature, causes, diagnosis, and management. Allergol Int 68 : 413-419, 2019
PubMed
10) Sasaki T, Nakajima M, Kawabata S, et al : Acute eosinophilic pneumonia induced by cigarette smoke. Nihon Kyobu Shikkan Gakkai Zasshi 35 : 89-94, 1997
PubMed
11) Uchihara T, Haranaga S, Azuma M, et al : A case of acute eosinophilic pneumonia that developed after changing cigarette brands. J Nihon Kokyuki Gakkai Zasshi 45 : 943-946, 2007
 
12) Rom WN, Weiden M, Garcia R, et al : Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med 166 : 797-800, 2002
 
13) Shorr AFSS, Cersovsky SB, Shanks GD, et al : Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. J Am Med Assoc 292 : 2997-3005, 2004
 
14) Mochimaru H, Kawamoto M, Fukuda Y, et al : Clinicopathological differences between acute and chronic eosinophilic pneumonia. Respirology 10 : 76-85, 2005
PubMed
15) Johkoh T, Muller NL, Akira M, et al : Eosinophilic lung diseases : diagnostic accuracy of thin-section CT in 111 patients. Radiology 216 : 773-780, 2000
PubMed
16) Takei R, Arita M, Kumagai S, et al : Traction bronchiectasis on high-resolution computed tomography may predict fatal acute eosinophilic pneumonia. Respir Invest 57 : 67-72, 2019
 
17) Gaensler EA, Carrington CB : Peripheral opacities in chronic eosinophilic pneumonia : the photographic negative of pulmonary edema. Am J Roentgenol 128 : 1-13, 1977
 
P.126 掲載の参考文献
1) Judson MA, Baughman RP, Teirsetin AS, et al : Defining organ involvement in sarcoidosis : the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 16 : 75-86, 1999
PubMed
2) Hunninghake GW, Costabel, Ando M, et al : ATS/ERS/WASOG statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), The European Respiratory Society (ERS), and The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. Am J Respir Crit Care Med 16 : 149-173, 1999
 
3) Crouser ED, Maier LA, Wilson KC, et al : Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respi Crit Care Med 201 : e26-e51, 2020
 
4) 日本サルコイドーシス/肉芽腫性疾患学会診断基準改定委員会 : サルコイドーシスの診断基準と診断の手引き-2006. 日サ会誌 26 : 77-82, 2006
 
5) Abe C, Iwai K, Mikami R, et al : Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralblatt fur Bakteriologie Mikrobiologie und Hygiene. 1984 ; Seris A 3256 ; 541-547.
 
6) Eishi Y, Suga M, Ishige I, et al : Quantitative analysis of mycobacterial and propionibacteral DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Microbiol 40 : 198-204, 2002
 
7) Negi M, Takemura T, Guzman J, et al : Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol 25 : 1284-1297, 2012
PubMed
8) Eishi Y : Etiologic aspect of sarcoidosis as an allergic endogenous infection cuased by Propionibacyerium acnes. Respir Investig 51 : 56-68, 2013
 
9) Brownell I, Ramirez-Valle F, Sanchez M, et al : Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 45 : 899-905, 2011
PubMed
10) Morimoto T, Azuma A, Abe S, et al : Epidemiology of sarcoidosis in Japan. Eur Respir J 31 : 372-379, 2008
PubMed
11) Iwai K, Tachibana T, Takemura T, et al : Pathological studies on sarcodisosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 43 : 372-376, 1993
PubMed
12) Iwai K, Takemura T, Kitaichi M, et al : Pathological studies on sarcoidosis autopsy. II. Early change, mode pf progression and death pattern. Acta Pathologica Jpn 43 : 377-385, 1993
 
13) Nishimura K, Ito H, Kitaichi M, et al : Pulmonary sarcoidosis : correlation of CT and histopatholoc findings. Radiology 189 : 105-109, 1993
 
14) Sawahata M, Johkoh T, Kawanobe T, et al : Computed tomography images of fibrotic pulmonary sarcoidosis leading to chronic respiratory failure. J Clin Med 9 : 142, 2020
 
15) Nakajima T, Yasufuku K, Kurosu K, et al : The role of EBUS-TBNA for the diagnosis of sarcoidosis-comparison with other bronchoscopic diagnostic modalities. Respir Med 103 : 1796-1800, 2009
 
16) Ravaglia C, Wells AU, Tomassetti A, et al : Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung disease : a large cohort of 699 patients. Pulm Med 19 : 16, 2019
 
17) Rosen Y : Sarcoidosis. in Dail DH, Hammar SP (eds) : Pulmonary Pathology, New York, Springer-Verlag, 1993. p 615
 
18) 武村民子, 生島壮一郎, 安藤常浩他 : サルコイドーシス肺における構築改変-66剖検肺の病理学的検討. 日サ会誌 23 : 43-52, 2003
 
19) Rosen Y, Moon S, Huang CT, et al : Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med 101 : 170-174, 1977
PubMed
20) Takemura T, Saiki S, Matsui Y, et al : Pulmonary vascular involvement in sarcoidosis : A report of 40 autopsy cases. Hum Pathol 23 : 1216-1223, 1992
PubMed
21) Baughman RP, Engel PJ, Nathan S : Pulmonary hypertension in sarcoidosis. Clin Chest Med 36 : 703-714, 2015
PubMed
22) Takemura T, Matsui Y, Oritsu M, et al : Pulmonary vascular involvement in sarcoidosis : granulomatous angiitis and microangiopaythy in transbronchial lung biopsies. Virchows Archiv Pathol Anat 418 : 361-368, 1991
PubMed
23) James G : Granuloma formation. in Sarcoidosis and Other Granulomatous Disorders. Marcel Dekker, New York, 1998, pp20-43
 
24) Liebow AA : The J. Burns Amberson lecture-pulmonary angiitis and granulomatosis. Am Rev Respir Dis 108 : 1-18, 1973
 
25) Rosen Y : Four decades of necrotizing sarcoid graulomatosis. What do we know now? Arch Pathol Lab Med 139 : 252-262, 2015
 
26) Handa T, Nagai S, Kitaichi M, et al : Long-term complications and prognosis of chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis 26 : 24-31, 2009
PubMed
27) 北市正則 : サルコイドーシス, 慢性ベリリウム肺および過敏性肺臓炎の肺病変の病理組織岳的比較検討. 日胸疾会誌 22 : 769-781, 1984
 
28) 倉持仁, 白井祐, 大場岳彦他 : 豊胸術後に発症し, 特異な肺野病変を呈したサルコイドーシスの1例. 日サ会誌 24 : 49-55, 2004
 
P.134 掲載の参考文献
1) Umehara H, Okazaki K, Masaki Y, et al : Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22 : 21-30, 2012
PubMed
2) Fujinaga Y, Kadoya M, Kawa S, et al : Characteristic findings in images of extra-pancreatic lesions associated with autoimmune pancreatitis. Eur J Radiol 76 : 228-238, 2010
PubMed
3) Zen Y, Kitagawa S, Minato H, et al : IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 36 : 710-717, 2005
PubMed
4) 寺崎泰弘, 福田悠 : 肺・呼吸器領域とIgG4関連疾患. 腎と透析 73 : 681-685, 2012
Medical*Online
5) 寺崎泰弘 : 肺・呼吸器領域のIgG4 関連疾患の特徴と鑑別 病理学的診断基準にむけて. びまん性肺疾患調査研究報告書, 2013, pp165-173
 
6) Matsui S, Hebisawa A, Sakai F, et al : Immunoglobulin G4-related lung disease : clinicoradiological and pathological features. Respirology 18 : 480-487, 2013
PubMed
7) 寺崎泰弘 : 呼吸器病変. 岡崎和一, 川茂幸編集主幹 : 最新IgG4関連疾患, 改訂第2版, 診断と治療社, 2019, pp81-88
 
8) Terasaki Y, Ikushima S, Matsui S, et al : Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease. Histopathology 70 : 1114-1124, 2017
 
9) Yamashita K, Haga H, Kobashi Y, et al : Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis : report of 3 cases and review of the literature. Am J Surg Pathol 32 : 1620-1626, 2008
PubMed
10) Sasaki T, Akiyama M, Kaneko Y, et al : Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease. RMD Open 3 : e000432, 2017
 
11) Nishimura MF, Igawa T, Gion Y, et al : Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease : A clinicopathological study in comparison with IgG4-related disease. J Pers Med 10 : 269, 2020.
 
12) Otani K, Inoue D, Fujikura K, et al : Idiopathic multicentric Castleman's disease : a clinicopathologic study in comparison with IgG4-related disease. Oncotarget 9 : 6691-6706, 2018
 
13) Guinee DG Jr : Update on nonneoplastic pulmonary lymphoproliferative disorders and related entities. Arch Pathol Lab Med 134 : 691-701, 2010
PubMed
14) Leslie KO, Wick MR : Inflammatory pseudotumor-plasma cell granuloma of the lung. in Practical Pulmonary Pathology-A Diagnostic Approach, Elsevier, Pliladelphia, 2011, pp649-651
 
15) Zen Y, Inoue D, Kitao A, et al : IgG4-related lung and pleural disease : a clinicopathologic study of 21 cases. Am J Surg Pathol 33 : 1886-1893, 2009
PubMed
16) Shrestha B, Sekiguchi H, Colby TV, et al : Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis : report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 33 : 1450-1462, 2009
PubMed
17) Ikeda S, Sekine A, Baba T, et al : Abundant immunoglobulin (Ig) G4-positive plasma cells in interstitial pneumonia without extrathoracic lesions of IgG4-related disease : Is this finding specific to IgG4-related lung disease? Histopathology 70 : 242-252, 2017
PubMed
18) Komatsu M, Yamamoto H, Matsui S, et al : Seventeen cases of "IgG4-positive interstitial pneumonia" characterized by elevated serum IgG4 levels and IgG4-positive plasma cell infiltrations in the lungs. European Respiratory Journal 56 (suppl 64) : 750, 2020
 
19) Shiokawa M, Kodama Y, Kuriyama K, et al : Pathogenicity of IgG in patients with IgG4-related disease. Gut 65 : 1322-1332, 2016
PubMed
P.141 掲載の参考文献
1) 吉崎和幸, 岡本真一郎, 川端浩他 : キャッスルマン病診療の参照ガイド. 臨床血液 58 : 97-107, 2017
 
2) キャッスルマン病診療ガイドライン作成ワーキンググループキャッスルマン病診療ガイドライン統括委員会 : キャッスルマン病診療ガイドライン 令和2年度初版, 2020.11.18. (https://castleman.jp/content/files/guideline_20201118.pdf)
 
3) Fujimoto S, Koga T, Kawakami A, et al : Tentative diagnostic criteria and disease severity classification for Castleman disease : A report of the research group on Castleman disease in Japan. Mod Rheumatol 28 : 161-167, 2018
 
4) Fajgenbaum DC, Uldrick TS, Bagg A, et al : International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood 129 : 1646-1657, 2017
PubMed
5) Murakami M, Johkoh T, Hayashi S, et al : Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan. Mod Rheumatol 30 : 843-851, 2020
PubMed
6) 中外製薬 : アクテムラ全例調査の中間報告 (キャッスルマン病), 2016 October 5 (http://chugai-pharm.jp/hc/ss/pr/drug/act_via0400/report/scs/PDF/20140225_act_epmpv_safe_cd.pdf)
 
7) Ikushima S, Terasaki Y, Hebisawa A, et al : Analysis of multicentric Castleman's disease (MCD) with pulmonary lesions. Eur Respir J 42 : 5123, 2013
 
8) Terasaki Y, Ikushima S, Matsui S, et al : Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease. Histopathology 70 : 1114-1124, 2017
 
9) Johkoh T, Muller NL, Ichikado K, et al : Intrathoracic multicentric Castleman disease : CT findings in 12 patients. Radiology 209 : 477-481, 1998
PubMed
10) Yamashita K, Haga H, Kobashi Y, et al : Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis : report of 3 cases and review of the literature. Am J Surg Pathol 32 : 1620-1626, 2008
PubMed
11) 森茂郎, 毛利昇, 内田俊和他 : 著しい多クローン性高免疫グロブリン血症と全身リンパ節の高度の形質細胞増生を呈する症候群-形質細胞型Castlemanリンパ腫との異同. 日網内系会誌 20 : 補冊 : 85-94, 1980
 
12) Kojima M, Nakamura N, Tsukamoto N, et al : Clinical implications of idiopathic multicentric castleman disease among Japanese : a report of 28 cases. Int J Surg Patho l16 : 391-398, 2008
 
13) 高井和江, 新國公司, 渋谷宏行他 : 発熱, 胸腹水, 肝脾腫を伴い, 骨髄に軽度の線維化を認める血小板減少症. 臨床血液 51 : 320-325, 2010
 
14) Iwaki N, Fajgenbaum DC, Nabel CS, et al : Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol 91 : 220-226, 2016
PubMed
15) Masaki Y, Kawabata H, Takai K, et al : Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version. Int J Hematol 103 : 686-692, 2016
PubMed
P.147 掲載の参考文献
1) Ciba Guest Symposium : Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax 14 : 286, 1959
 
2) American Thoracic Society : Standards for the diagnosis and care patients with chronic obstructive pulmonary disease and asthma. Am Rev Respir Dis 36 : 225-244, 1987
 
3) 日本呼吸器学会COPD ガイドライン第5版作成委員会 編 : COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 2018, 第5版, メディカルレビュー社, 2018
 
4) Yamanaka A : Morphopathology of chronic pulmonary emphysema. Acta Pathol Jpn 15 : 33-39, 1965
PubMed
5) Pratt PC : Dail and Hammar's Pulmonary Pathology (2nd ed), Springer, 1994, pp847-865
 
6) Thurlbeck WM : Pathology of the Lung (2nd ed), Thieme Medical Publishers, 1995, pp739-825
 
7) Victor LR, Philip TC : Dail and Hammar's Pulmonary Pathology, Vol.1 (3rd ed), Springer, 2008, pp866-885
 
8) Snider GL, Kleinerman J, Thurlbeck WM, et al : The definition of emphysema. Report of a National Heart, Lung, and Blood Institute, Division of Lung Disease workshop. Am Rev Respir Dis 132 : 182-185, 1985
 
9) Wright JL : Emphysema : concepts under change-a pathologist's perspective. Mod Pathol 8 : 873-880, 1995
 
10) Cottin V, Numes H, Brillet PY, et al : Combined pulmonary fibrosis and emphysema : a distinct under recognized entity. Eur Respir J 25 : 586-593, 2005
 
11) World Health Organization : The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death 9 December 2020
 
12) 厚生労働省 : 人口動態調査. https://www.mhlw.go.jp/toukei/list/81-1a.html
 
13) Heard BE. Pathology of pulmonary emphysema : Methords of study. Am Rev Respir Dis 82 : 792-799, 1960
 
14) Hogg JC, Pare PD, Hackett TI : The contribution of small airway obstruction to pathogenesis of chronic obstructive pulmonary disease. Physiol Rev 97 : 529-552, 2017
 
15) Tsai YF, Hwang TI : Neutrophil elastase inhibitors : a patent review and potential applications for inflammatory lung disease. Expert Opin Ther Pat 25 : 1145-1158, 2015
 
16) Zong DD, Ouyang RY, Chen P, et al : Epigenetic mechanisms in chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci 19 : 844-856, 2015
 
17) MizumuraK, Maruoka S, Gon Y, et al : The role of necroptosis in pulmonary disease. Respir Investing 54 : 407-412, 2016
 
18) Lange P, Celli B, Augsti A, et al : Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 373 : 111-122, 2015
PubMed
P.150 掲載の参考文献
1) Sahn SA, Heffner JE : Spontaneous pneumothorax. N Engl J Med 342 : 868-874, 2000
PubMed
2) 北川正信, 北川知行, 森田豊彦 : 気腫性嚢胞の病理. 日胸 27 : 475-486, 1968
 
3) 益田貞彦, 斎木茂樹 : 自然気胸-blebの形態像とその破綻に関して. 日胸外会誌 29 : 1847-1855, 1981
 
4) Churg A : Pneumothorax. in Thurlbeck W, Churg AM (eds) : Pathology of the Lung (2nd ed), New York, Thieme Medical Publishers, 1995, pp1076-1080
 
5) Noppen M : Do blebs cause primary spontaneous pneumothorax? Con : blebs do not cause primary spontaneous pneumothorax. J Bronchol 9 : 319-323, 2002
 
6) Grundy S, Bentley A, Tschopp JM : Primary spontaneous pneumothorax : a diffuse diseas of the pleura. Respiration 83 : 185-189, 2012
 
7) Kurmar V, Abbas AK, Aster JC (eds) : Robbins & Cottran Pathologic Basis of Pathology (10th ed), Elsevier, Philadelphia, 2021, pp71-114
 
8) 緒方知三郎. 病理学入門, 南山堂, 1968, pp150-161
 
9) Morgan MD, Edwards JM, Matthews HR : Origin and behavior of emphysematous bullae. Thorax 44 : 533-538, 1989
 
P.158 掲載の参考文献
1) Histiocytosis syndromes in children. Writing Group of the Histiocyte Society. Lancet 1 (8526) : 208-209, 1987
 
2) Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127 : 2672-2681, 2016
PubMed
3) Badalian-Very G, Vergilio JA, Degar BA, et al : Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116 : 1919-1923, 2010
PubMed
4) Yousem SA, Dacic S, Nikiforov YE, et al : Pulmonary Langerhans cell histiocytosis : profiling of multifocal tumors using next-generation sequencing identifies concordant occurrence of BRAF V600E mutations. Chest 143 : 1679-1684, 2013
PubMed
5) Allen CE, Li L, Peters TL, et al : Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol 184 : 4557-4567, 2010
PubMed
6) 岩井和郎, 高橋潔, 内藤眞 : Histiocytosis-Xに含まれる三疾患, 好酸球性肉芽腫症, Hand-Shuller-Christian病およびLetterer-Siwe病の病像の比較. 日網内会誌 25 : 267-278, 198
 
7) Lorillon G, Tazi A : How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev 26 : 170070, 2017
 
8) Gaensler EA, Carrington CB : Open biopsy for chronic diffuse infiltrative lung disease : clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 30 : 411-426, 1980
PubMed
9) Baqir M, Vassallo R, Maldonado F, et al : Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis. J Bronchology Intervent Pulmonol 20 : 309-312, 2013
 
10) Canuet M, Kessler R, Jeung MY, et al : Correlation between high-resolution computed tomography findings and lung function in pulmonary Langerhans cell histiocytosis. Respiration 74 : 640-646, 2007
PubMed
11) Fartoukh M, Humbert M, Capron F, et al : Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 161 : 216-223, 2000
PubMed
12) Vassallo R, Ryu JH, Colby TV, et al : Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 342 : 1969-1978, 2000
PubMed
13) 河端美則他 : 肺好酸球性肉芽腫症の病理と病理発生をめぐって. 呼吸 11 : 1317-1323, 1996
Medical*Online
14) Suri H, Yi ES, Nowakowski GS, et al : Pulmonary Langerhans cell histiocytosis. Orphanet J Rare Dis 7 : 16, 2012
PubMed
15) Brauner MW, Grenier P, Tijani K, et al : Pulmonary Langerhans cell histiocytosis : evolution of lesions on CT scans. Radiology 204 : 497-502, 1997
 
16) Tazi A, Soler P, Hance AJ : Adult pulmonary Langerhans' cell histiocytosis. Thorax 55 : 405-416, 2000
PubMed
17) 河端美則 : 肺Langerhans細胞肉芽腫症の病理と病態. 病理と臨床 24 : 904-912, 2006
Medical*Online
18) Colby TV, Lombard C : Histiocytosis X in the lung. Hum Pathol 14 : 847-856, 1983
PubMed
19) Travis WD, Borok Z, Roum JH, et al : Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 17 : 971-986, 1993
PubMed
20) Kambouchner M, Basset F, Marchal J, et al : Threedimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Am J Respir Crit Care Med 166 : 1483-1490, 2002
 
21) Harari S, Brenot F, Barberis M, et al : Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension. Chest 111 : 1142-1144, 1997
PubMed
22) Janin A, Torpier G, Capron M, et al : Immunopathological study of eosinophils in eosinophilic granuloma of bone : evidence for release of three cationic proteins and subsequent uptake in macrophages. Virchows Arch A Pathol Anat Histopathol 421 : 255-261, 1992
PubMed
23) Kilpatrick SE, Wenger DE, Gilchrist GS, et al : Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer 76 : 2471-2484, 1995
 
24) Favara BE, Steele A : Langerhans cell histiocytosis of lymph nodes : a morphological assessment of 43 biopsies. Pediatr Pathol Lab Med 17 : 769-787, 1997
PubMed
25) Kawabata Y, Tomichi N, Tanino MA, et al : The role of eosinophils in necrosis mainly in single-system Langerhans cell histiocytosis. J Histology & Histopathology 2021 http://www.hoajonline.com/journals/pdf/2055-091X-8-1.pdf
 
26) Rolland A, Guyon L, Gill M, et al : Increased blood myeloid dendritic cells and dendritic cell-poietins in Langerhans cell histiocytosis. J Immunol 174 : 3067-3071, 2005
PubMed
P.162 掲載の参考文献
1) Chung A, Wilgus ML, Fishbein G, et al : Pulmonary and bronchiolar involvement in Sjogren's syndrome. Semin Respir Crit Care Med 40 : 235-254, 2019
 
2) Luppi F, Sebastiani M, Sverzellati N, et al : Lung complications of Sjogren syndrome. Eur Respir Rev 29 : 200021, 2020
PubMed
3) Lechtman S, Debray MP, Crestani B, et al : Cystic lung disease in Sjogren's syndrome : An observational study. Joint Bone Spine 84 : 317-321, 2017
 
4) Martinez-Balzano CD, Touray S, Kopec S : Cystic lung disease among patients with Sjogren syndrome : frequency, natural history, and associated risk factors. Chest 150 : 631-639, 2016
PubMed
5) Gupta N, Wikenheiser-Brokamp KA, Fischer A, et al : Diffuse cystic lung disease as the presenting manifestation of Sjogren syndrome. Ann Am Thorac Soc 13 : 371-375, 2016
PubMed
6) Gupta N, Vassallo R, Wikenheiser-Brokamp KA, et al : Diffuse cystic lung disease. part II. Am J Respir Crit Care Med 192 : 17-29, 2015
PubMed
7) Cordier JF, Johnson SR : Multiple cystic lung diseases. in Cordier JF (ed) : "Orphan Lung Disease", Eur Respir Soc Publications, 2011, pp46-83
 
8) Rowan C, Hansell DM, Renzoni E, et al : Diffuse cystic lung disease of unexplained cause with coexistent small airway disease : a possible causal relationship? Am J Surg Pathol 36 : 228-234, 2012
PubMed
P.167 掲載の参考文献
1) Kumar V, Abbas AK, Aster JC : Amyloidosis. In Kumar V, Abbas AK, Aster JC (eds) : Robbins Basic Pathology, Elsevier, Philadelphia, 2018, pp182-187
 
2) 大越忠, 内木宏 : アミロイド線維の形成・沈着と臓器障害の分子機構. 医学のあゆみ 258 : 615-620, 2016
Medical*Online
3) Benson MD, Buxbaum JN, Eisenberg DS, et al : Amyloid nomenclature 2020 : update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 27 : 217-222, 2020
PubMed
4) 内木宏 : 全身性アミロイドーシス. 生体の科学 71 : 464-465, 2020
 
5) 大越忠, 小澤大, 山口格他 : アミロイドーシスの発症メカニズムについて. 病理と臨床 34 : 454-459, 2016
Medical*Online
6) 小林英 : 全身性疾患の肺病変 気管支・肺アミロイドーシス. 医学のあゆみ 別冊 : 415-417, 2013
 
7) Baqir M, Roden AC, Moua T : Amyloid in the Lung. Semin Respir Crit Care Med 41 : 299-310, 2020
PubMed
8) Khoor A, Colby TV : Amyloidosis of the Lung. Arch Pathol Lab Med 141 : 247-254, 2017
PubMed
9) 金森斎, 松田良 : 限局性結節性肺アミロイドーシス. 日本臨牀 別冊 : 640-643, 2013
 
10) 北村淳, 櫻井隆, 冨田和他 : 稀な呼吸器疾患 気管支・肺アミロイドーシス. 呼吸 27 : 702-706, 2008
 
11) Shiozaki T, Sato N, Hayashi T, et al : Wild-type ATTR amyloidosis may be associated with unexpected death among the elderly. Leg Med (Tokyo) 41 : 101634, 2019
PubMed
12) Pinney JH, Lachmann HJ : Amyloidosis and the lung. in Cordier J-F (ed) : Orphan Lung Diseases, European Respiratory Society, 2011, pp152-170
 
13) 藤井浩 : 孤立性結節型肺アミロイドーシス. 日本臨牀 別冊 : 499-502, 1998
 
14) Grogg KL, Aubry MC, Vrana JA, et al : Nodular pulmonary amyloidosis is characterized by localized immunoglobulin deposition and is frequently associated with an indolent B-cell lymphoproliferative disorder. Am J Surg Pathol 37 : 406-412, 2013
PubMed
15) Bhargava P, Rushin JM, Rusnock EJ, et al : Pulmonary light chain deposition disease : report of five cases and review of the literature. Am J Surg Pathol 31 : 267-276, 2007
PubMed
16) 村田喜代史, 上甲剛, 村山貞之, 他編 : 胸部のCT, 第4版, メディカル・サイエンス・インターナショナル, 2018
 
17) Ueda M, Ando Y, Haraoka K, Terasaki Y, et al : Aging and transthyretin-related amyloidosis : pathologic examinations in pulmonary amyloidosis. Amyloid 13 : 24-30, 2006
PubMed
18) 田崎雅義, 大林光念, 安東由喜雄, 他 : アミロイドーシスにおける病理学的検査のUp to date. 臨床病理 68 : 768-773, 2020
Medical*Online
19) Vrana JA, Gamez JD, Madden BJ, et al : Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood 114 : 4957-4959, 2009
PubMed
20) 大橋健一 : 免疫染色によるアミロイドーシス病型診断 現状と将来の取り組み. 病理と臨床 36 : 710-712, 2018
Medical*Online
21) 勝馬愛, 清水章 : 軽・重鎖沈着症. 腎と透析 84 : 533-538, 2018
Medical*Online
22) 小松田敦, 涌井秀 : 単クローン性免疫グロブリン沈着症. 日本臨牀 別冊 : 435-438, 2012
 
23) Yee M, Delahunt B, Russell PA : Nodular pulmonary light chain deposition disease. Pathology 48 : 515-518, 2016
PubMed
24) Colombat M, Caudroy S, Lagonotte E, et al : Pathomechanisms of cyst formation in pulmonary light chain deposition disease. Eur Respir J 32 : 1399-1403, 2008
PubMed
25) Colombat M, Stern M, Groussard O, et al : Pulmonary cystic disorder related to light chain deposition disease. Am J Respir Crit Care Med 173 : 777-780, 2006
PubMed
26) Baqir M, Moua T, White D, et al : Pulmonary nodular and cystic light chain deposition disease : A retrospective review of 10 cases. Respir Med 164 : 105896, 2020
PubMed
27) Sheard S, Nicholson AG, Edmunds L, et al : Pulmonary lightchain deposition disease : CT and pathology findings in nine patients. Clin Radiol 70 : 515-522, 2015
 
28) Moutsopoulos HM, Steinberg AD, Fauci AS, et al : High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. J Immunol 130 : 2663-2665, 1983
 
29) Kassan SS, Thomas TL, Moutsopoulos HM, et al : Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89 : 888-892, 1978
PubMed
30) 御手洗哲, 佐野達, 鬼澤信 : 単クローン性軽鎖重鎖沈着病. 日本臨牀 別冊 : 510-513, 2014
 
31) Kunnath-Velayudhan S, Larsen BT, Coley SM, et al : Masson trichrome and sulfated alcian blue stains distinguish light chain deposition disease from amyloidosis in the lung. Am J Surg Pathol 45 : 405-413, 2021
PubMed
P.174 掲載の参考文献
1) Hayashi T, Kumasaka T, Mitani K, et al : Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis : a clinicopathologic study of 10 patients. Am J Surg Pathol 35 : 1776-1785, 2011
PubMed
2) Henske EP, McCormack FX : Lymphangioleiomyomatosis-a wolf in sheep's clothing. J Clin Invest 122 : 3807-3816, 2012
 
3) 山中晃, 斉木茂樹 : びまん性過誤腫性肺脈管筋腫症. 肺と心 17 : 171-181, 1970
 
4) Carsillo T, Astrinidis A, Henske EP : Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A 97 : 6085-6090, 2000
PubMed
5) Sato T, Seyama K, Fujii H, et al : Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 47 : 20-28, 2002
PubMed
6) McCormack FX, Inoue Y, Moss J, et al : Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364 : 1595-1606, 2011
PubMed
7) Kumasaka T, Seyama K, Mitani K, et al : Lymphangiogenesis in lymphangioleiomyomatosis : its implication in the progression of lymphangioleiomyomatosis. Am J Surg Pathol 28 : 1007-1016, 2004
PubMed
8) Hayashi T, Kumasaka T, Mitani K, et al : Bronchial involvement in advanced stage lymphangioleiomyomatosis : histopathologic and molecular analyses. Hum Pathol 50 : 34-42, 2016
PubMed
9) Seyama K, Kumasaka T, Souma S, et al : Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis. Lymphat Res Biol 4 : 143-152, 2006
PubMed
10) Young LR, Inoue Y, McCormack FX : Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med 358 : 199-200, 2008
PubMed
11) Sekimoto Y, Suzuki K, Okura M, et al : Uncommon radiologic computed tomography appearances of the chest in patients with lymphangioleiomyomatosis. Sci Rep 11 : 7170, 2021
PubMed
12) Matsui K, Beasley MB, Nelson WK, et al : Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol 2001 25 : 479-484, 2001
PubMed
13) Yang Q, Guan KL : Expanding mTOR signaling. Cell Res 17 : 666-681, 2007
PubMed
P.181 掲載の参考文献
1) Birt AR, Hogg GR, Dube WJ : Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 113 : 1674-1677, 1977
PubMed
2) Toro JR, Glenn G, Duray P, et al : Birt-Hogg-Dube syndrome : a novel marker of kidney neoplasia. Arch Dermatol 135 : 1195-1202, 1999
PubMed
3) Nickerson ML, Warren MB, Toro JR, et al : Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell 2 : 157-164, 2002
 
4) Toro JR, Pautler SE, Stewart L, et al : Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome. Am J Respir Crit Care Med 175 : 1044-1053, 2007
PubMed
5) Schmidt LS, Warren MB, Nickerson ML, et al : Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 69 : 876-882, 2001
PubMed
6) Khoo SK, Giraud S, Kahnoski K, et al : Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet 39 : 906-912, 2002
PubMed
7) van Steensel MA, Verstraeten VL, Frank J, et al : Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dube patients. J Invest Dermatol 127 : 588-593, 2007
PubMed
8) Schmidt LS, Nickerson ML, Warren MB, et al : Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet 76 : 1023-1033, 2005
PubMed
9) Schmidt LS, Linehan WM : FLCN : The causative gene for Birt-Hogg-Dube syndrome. Gene 640 : 28-42, 2018
PubMed
10) Warren MB, Torres-Cabala CA, Turner ML, et al : Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues. Mod Pathol 17 : 998-1011, 2004
PubMed
11) Toro JR, Wei MH, Glenn GM, et al : BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome : a new series of 50 families and a review of published reports. J Med Genet 45 : 321-331, 2008
 
12) Furuya M, Yao M, Tanaka R, et al : Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dube syndrome. Clin Genet 90 : 403-412, 2016
PubMed
13) Kunogi M, Kurihara M, Ikegami TS, et al : Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet 47 : 281-287, 2010
PubMed
14) Iwabuchi C, Ebana H, Ishiko A, et al : Skin lesions of Birt-Hogg-Dube syndrome : Clinical and histopathological findings in 31 Japanese patients who presented with pneumothorax and/or multiple lung cysts. J Dermatol Sci 89 : 77-84, 2018
PubMed
15) Menko FH, van Steensel MAM, Giraud S, et al : Birt-Hogg-Dube syndrome : diagnosis and management. Lancet Oncol 10 : 1199-1206, 2009
 
16) Tobino K, Gunji Y, Kurihara M, et al : Characteristics of pulmonary cysts in Birt-Hogg-Dube syndrome : thin-section CT findings of the chest in 12 patients. Eur J Radiol 77 : 403-409, 2011
PubMed
17) Agarwal PP, Gross BH, Holloway BJ, et al : Thoracic CT findings in Birt-Hogg-Dube syndrome. AJR Am J Roentgenol 196 : 349-352, 2011
PubMed
18) Mizobuchi T, Kurihara M, Ebana H, et al : A total pleural covering of absorbable cellulose mesh prevents pneumothorax recurrence in patients with Birt-Hogg-Dube syndrome. Orphanet J Rare Dis 13 : 78, 2018
PubMed
19) Kumasaka T, Hayashi T, Mitani K, et al : Characterization of pulmonary cysts in Birt-Hogg-Dube syndrome : histopathological and morphometric analysis of 229 pulmonary cysts from 50 unrelated patients. Histopathology 65 : 100-110, 2014
PubMed
20) Medvetz DA, Khabibullin D, Hariharan V, et al : Folliculin, the product of the Birt-Hogg-Dube tumor suppressor gene, interacts with the adherens junction protein p0071 to regulate cell-cell adhesion. PLoS One 7 (11) : e47842, 2012
PubMed
21) Goncharova EA, Goncharov DA, James ML, et al : Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK. Cell Rep 7 : 412-423, 2014
PubMed
22) Furuya M, Tanaka R, Koga S, et al : Pulmonary cysts of Birt-Hogg-Dube syndrome : a clinicopathologic and immunohistochemical study of 9 families. Am J Surg Pathol 36 : 589-600, 2012
PubMed
23) Furuya M, Nakatani Y : Pathology of Birt-Hogg-Dube syndrome : A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review. Pathol Int 69 : 1-12, 2019
 
P.186 掲載の参考文献
1) 難治性稀少部位子宮内膜症の集学的治療のための分類・診断・治療ガイドライン作成」研究班 : 稀少部位子宮内膜症診療ガイドライン, 診断と治療社, 2018
 
2) Melton LJ 3rd, Hepper NG, Offord KP : Incidence of spontaneous pneumothorax in Olmsted County, Minnesota : 1950 to 1974. Am Rev Respir Dis 120 : 1379-1382, 1979
PubMed
3) Gupta D, Hansell A, Nichols T, et al : Epidemiology of pneumothorax in England. Thorax 55 : 666-671, 2000
PubMed
4) Alifano M, Trisolini R, Cancellieri A, et al : Thoracic endometriosis : current knowledge. Ann Thorac Surg 81 : 761-769, 2006
PubMed
5) Fukuoka M, Kurihara M, Haga T, et al : Clinical characteristics of catamenial and non-catamenial thoracic endometriosis-related pneumothorax. Respirology 20 : 1272-1276, 2015
PubMed
6) Haga T, Kataoka H, Ebana H, et al : Thoracic endometriosisrelated pneumothorax distinguished from primary spontaneous pneumothorax in females. Lung 192 : 583-587, 2014
 
7) Rousset P, Rousset-Jablonski C, Alifano M, et al : Thoracic endometriosis syndrome : CT and MRI features. Clin Radiol 69 : 323-330, 2014
PubMed
8) Rousset P, Gregory J, Rousset-Jablonski C, et al : MR diagnosis of diaphragmatic endometriosis. Eur Radiol 26 : 3968-3977, 2016
PubMed
9) Haga T, Kumasaka T, Kurihara M, et al : Immunohistochemical analysis of thoracic endometriosis. Pathol Int 63 : 429-434, 2013
PubMed
10) Sampson JA : Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 3 : 93-110 143, 1927
 
11) Lagana AS, Garzon S, Gotte M, et al : The Pathogenesis of endometriosis : molecular and cell biology insights. Int J Mol Sci 20 : 5615, 2019
 
12) Bulun SE, Yilmaz BD, Sison C, et al : Endometriosis. Endocr Rev 40 : 1048-1079, 2019
PubMed
P.191 掲載の参考文献
1) Engleman P, Liebow AA, Gmelich J, et al : Pulmonary hyalinizing granuloma. Am Rev Respir Dis 115 : 997-1008, 1977
PubMed
2) Lhote R, Haroche J, Duron L, et al : Pulmonary hyalinizing granuloma : a multicenter study of 5 new cases and review of the 135 cases of the literature. Immunol Res 65 : 375-385, 2017
PubMed
3) Yousem SA, Hochholze L : Pulmonary hyalinizing granuloma. Am J Clin Pathol 87 : 1-6, 1987
 
4) Atagi S, Sakatani M, Akira M, et al : Pulmonary hyalinizing granuloma with Castleman's disease. Intern Med 33 : 689-691, 1994
 
5) Takeuchi N, Arai T, Kitaichi M, et al : A comorbid case of multicentric Castleman's disease and pulmonary hyalinising granuloma successfully treated with tocilizumab and corticosteroid. BMJ Case Rep 2013 : bcr2013010233, 2013
 
6) Kojima M, Nakamura S, Ban S, et al : Primary pulmonary low-grade marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with prominent hyalinosis-A case report. Pathol Res Pract 198 : 685-688, 2002
PubMed
7) Ren Y, Raitz EN, Lee KR, et al : Pulmonary small lymphocytic lymphoma (mucosa-associated lymphoid tissue type) associated with pulmonary hyalinizing granuloma. Chest 120 : 1027-1030, 2001
PubMed
8) Chalaoui J, Gregoire P, Sylvestre J, et al : Pulmonary hyalinizing granuloma : a cause of pulmonary nodules. Radiology 152 : 23-26, 1984
PubMed
9) Patel Y, Ishikawa S, MacDonnell KF : Pulmonary hyalinizing granuloma presenting as multiple cavitary calcified nodules. Chest. 100 : 1720-1721, 1991
PubMed
10) Lindholn KE, Groot P, Moran CA : Fibrosing/sclerosing lesions of the mediastinum : A review. Adv Anat Pathol 26 : 235-240, 2019
 
P.195 掲載の参考文献
1) WHO classification of tumours editorial board : Thoracic tumours. International agency for research on cancer, Lyon, 2021
 
2) 橋本洋 : 炎症性偽腫瘍をどうとらえるか. 病理と臨床 25 : 418-420, 2007
Medical*Online
3) 山本英崇, 小田義直 : 炎症性筋線維芽細胞性腫瘍とその周辺疾患. 病理と臨床 30 : 258-264, 2012
 
4) Matsubara O, Tan-Liu NS, Kenney RM, et al : Inflammatory pseudotumors of the lung : progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases. Hum Pathol 19 : 807-814, 1988
PubMed
5) Sagar AES, Jimenez CA, Shannon VR : Clinical and histopathologic correlates and management strategies for inflammatory myofibroblastic tumor of the lung. A case series and review of the literature. Med Oncol 35 : 102, 2018
 
6) Kurihara T, Suehara Y, Akaike K, et al : Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors. Sci Rep 10 : 18724, 2020
PubMed
7) Chang JC, Zhang L, Drilon AE, et al : Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements. J Thorac Oncol 14 : 825-834, 2019
PubMed
8) Yamamoto H, Yoshida A, Taguchi K, et al : ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology 69 : 72-83, 2016
PubMed
9) Zen Y, Inoue D, Kitao A, et al : IgG4-related lung and pleural disease : a clinicopathologic study of 21 cases. Am J Surg Pathol 33 : 1886-1893, 2009
PubMed
10) Inoue D, Zen Y, Abo H, et al : Immunoglobulin G4-related lung disease : CT findings with pathologic correlations. Radiology 251 : 260-270, 2009
PubMed
11) Bhagat P, Bal A, Das A, et al : Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor : a diagnostic dilemma. Virchows Arch 463 : 743-747, 2013
PubMed
12) Nishimura MF, Igawa T, Gion Y, et al : Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease : A clinicopathological study in comparison with IgG4-related disease. J Pers Med 10 : 269, 2020
 
13) Katzenstein LA : Diagnostic Atlas of Non-neoplastic Lung Disease, Springer, New York, 2016, pp278-280
 
14) 松原修, 中谷行雄, 四元秀毅 : 肺のリンパ増殖性疾患の概念の変遷と鑑別診断. 病理と臨床 17 : 122-134, 1999
Medical*Online
P.197 掲載の参考文献
1) Hanke R : Round atelectasis (spherical and cylindrical atelectasis). Contribution to the differential diagnosis of intrapulmonal round foci. Fortschr Geb Rontgenstr Nuklearmed 114 : 164-183, 1971
 
2) 中川誠, 菅谷将一, 松下明弘 : 増大傾向を示し肺癌との鑑別を要した円形無気肺の1例. 肺癌 49 : 456-460, 2009
Medical*Online
3) 岸本卓巳, 小崎晋司, 藤岡英樹 : 石綿曝露によって発生した円形無気肺の臨床的検討. 呼吸会誌 40 : 95-100, 2002
Medical*Online
4) 中川義久, 島津和康, 蛯原桃子 : アスベスト暴露に続発した円形無気肺8例の検討. 呼吸会誌 37 : 20-24, 1999
 
5) Hammar SP, Dodson RF : Dail and Hammar's Pulmonary Pathology, Vol 1 (3rd ed), Springer, 2008, pp986-988
 
P.203 掲載の参考文献
1) Gao YH, Guan WJ, Liu SX, et al : Aetiology of bronchiectasis in adults : a systemic literature review. Respirology 21 : 1376-1383, 2016
 
2) Nassar AA, Jaroszewsky DE, Helmers RA, et al : Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia : a systemic overview. Am J Respir Crit Care Med 184 : 8-16, 2011
 
3) Bush A, Floto RA : Pathophysiology, causes and genetics of paediatric and adult bronchiectasis. Respirology 24 : 1053-1062, 2019
PubMed
4) Elicker BM, Webb WR : Fundamentals of High-Resolution Lung CT (2nd ed), Wolters Kluwer, 2019
 
5) Mukhopadhyay S : Non-Neoplastic Pulmonary Pathology-An Algorithmic Approach to Histologic Findings in the Lung, Cambridge University Press, 2016
 
6) Katzenstein ALA : Diagnostic Atlas of Non-neoplasitc Lung Disease-A Practical Guide for Surgical Pathologists, demosMEDICAL, 2016
 
P.210 掲載の参考文献
1) 日本呼吸器学会編 : 難治性喘息診断と治療の手引き 2019, メディカルレビュー社, 2018
 
2) Aikawa T, Shimura S, Sasaki H, et al : Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 101 : 916-921, 1992
PubMed
3) Persson EK, Verstraete K, Heyndrickx I, et al : Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science 364 : eaaw4295, 2019
PubMed
4) Fahy JV, Locksley RM : Making asthma crystal clear. N Engl J Med 3819 : 882-884, 2019
 
5) Tyner JW, Kim EY, Ide K, et al : Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 116 : 309-321, 2006
PubMed
6) Ebina M, Yaegashi H, Takahashi T, et al : Distribution of smooth muscles along the bronchial tree. A morphometric study of ordinary autopsy lungs. Am Rev Respir Dis 141 : 1322-1326, 1990
 
7) Ebina M, Yaegashi H, Chiba R, et al : Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. Am Rev Respir Dis 141 : 1327-1332, 1990
PubMed
8) Ebina M, Takahashi T, Chiba T, et al : Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 148 : 720-726, 1993
PubMed
9) Ebina M : Remodeling of airway walls in fatal asthmatics decreases lymphatic distribution ; beyond thickening of airway smooth muscle layers. Allergol Int 57 : 165-174, 2008
PubMed
P.216 掲載の参考文献
1) Yousem SA, Colby TV, Carrington CB : Follicular bronchitis/bronchiolitis. Hum Pathol 16 : 700-706, 1985
PubMed
2) Lange W : Ueber eine eigenthuemliche Erkrankung der kleinen Bronchien und Bronchiolen. Dtsch Arch Klin Med 70 : 342, 1901
 
3) Epler GR, Colby TV, Mcloud TC, et al : Bronchiolitis obliterans organizing pneumonia. N Engl J Med 312 : 152-158, 1985
PubMed
4) American Thoracic Society : American Thoracic Society/European Thoracic Society International multidisciplinary consensus classification of the idiopathic international pneumonias : Am J Respir Crit Care Med 165 : 277-304, 2002
PubMed
5) Geddes DM, Corrin B, Brewerton DA, et al : Progressive airway obliteration in adults and its association with rheumatoid arthritis. Quart J Med 184 : 427-444, 1977
PubMed
6) Colby TV, Meyer JL : The clinical and histologic spectrum of bronchiolitis obliterans organizing pneumonia (BOOP). Semin Respir Med 13 : 119-133, 1992
 
7) 山中晃, 前田正博, 山本隆一 : 慢性閉塞性細気管支炎Bronchobronchiolitis obliteransを含む. 日本胸部臨床 45 : 539-554, 1986
 
8) 蛇澤晶, 朝川勝明, 杉野圭史他 : 閉塞性細気管支炎症候群をめぐって : 閉塞性細気管支炎の病理. 呼吸 27 : 265-274, 2008
 
9) Sugino K, Hebisawa A, Uekusa T, et al : Histopathological bronchial reconstruction of human bronchiolitis obliterans. Pathol Int 61 : 192-201, 2011
PubMed
10) Sugino K, Hebisawa A, Uekusa T, et al : Bronchiolitis obliterans associated with Stevens-Johnson syndrome : histopathological bronchial reconstruction of the whole lung and immunohistochemical study. Diagn Pathol 8 : 134, 2013
PubMed
11) Homma S, Kawabata M, Kishi K, et al : Bronchiolitis in Kartagener's syndrome. Eur Respir J 14 : 1332-1339, 1999
PubMed
12) Hasegawa Y, Shimokata K, Ichiyama S, et al : Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. Eur Respir J 13 : 934-937, 1999
PubMed
13) Kobayashi K, Ohshima N, Shimada M, et al : An autopsy case of unicentric Castleman's disease associated with bronchiolitis obliterans. Respirol Case Rep 2 : 105-107, 2014
 
14) Soubani AO, Uberti JP : Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 29 : 1007-1019, 2007
PubMed
15) Jan W, Van den Berg K, Geertsma A, et al : Bronchiolitis obliterans syndrome after lung transplantation and healthrelated quality of life. Am J Respir Crit Care Med 161 : 1937-1941, 2000
 
16) Lai RS, Chiang AA, Wu MT, et al : Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 348 : 83-85, 1996
PubMed
17) Kreiss K, Gomaa A, Kullman G, et al : Clinical bronchiolitis obliterans in workers at a micro-wave-popcorn plant. N Engl J Med 347 : 330-338, 2002
 
18) Estenne M, Maurer JR, Boehler A, et al : Bronchiolitis obliterans syndrome 2001 : an update of the diagnostic criteria. J Heart Lung Transplant 21 : 297-310, 2002
PubMed
19) Shitrit D, Bendayan D, Gidon S, et al : Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 24 : 1440-1443, 2005
PubMed
20) Iacono AT, Johnson BA, Grgurich WF, et al : A randomized trial of inhaled cyclosporine in lung transplant recipients. N Engl J Med 354 : 141-150, 2006
PubMed
21) Hollmen M, Tikkanen JM, Nykanen AI, et al : Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development. J Heart Lung Transplant 27 : 856-864, 2008
PubMed
22) Dosanjh A : Pirfenindone : anti-fibrotic agent with a potential therapeutic role in the management of transplantation patients. Eur J Pharmacol 536 : 219-222, 2006
PubMed
P.219 掲載の参考文献
1) Honma H, Yamanaka A, Tanimoto M, et al : Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest 83 : 63-69, 1983
 
2) 工藤翔二, 木村仁他 : びまん性汎細気管支炎にたいするマクロライド系抗生剤の小量長期投与の臨床効果. 日胸疾会誌 22 (増) : 254, 1984
 
3) Kudoh S, Azuma A, Yamamoto M, et al : Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157 : 1829-1832, 1998
PubMed
4) 斎木茂樹 : びまん性汎細気管支炎diffuse panbronchiolitis (DPB). 病理と臨床 15 : 625-629, 1997
Medical*Online
5) Kitaichi M : Pathology of diffuse panbronchiolitis from the view point of differential diagnosis. in Grassi C, Rizzato G, Pozzi E (eds) : Sarcoidosis and Other Granulomatous Disorders, Elsevier Science Publishers B.V. Amsterdam, 1988, 741
 
6) Kadota J, Mukae H, Fujii T, et al : Clinical similarities and differences between human T-cell lymphotropic virus type 1-associated bronchiolitis and diffuse panbronchiolitis. Chest 125 : 1239-1247, 2004
PubMed
7) Hayakawa H, Sato A, Imokawa S, et al, Diffuse panbronchiolitis and rheumatoid arthritis-associated bronchiolar disease : similarities and differences. Intern Med 37 : 504-508, 1998
PubMed
P.223 掲載の参考文献
1) Rednic S, Damian L, Talarico R, et al : Relapsing polychondritis : state of the art on clinical practice guidelines. RMD Open 4 (Suppl 1) : e000788, 2018
 
2) McAdam LP, O'Hanlan MA, Bluestone R, et al : Relapsing polychondritis : prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55 : 193-215, 1976
 
3) 岡寛, 山野嘉久, 遊道和夫他 : 再発性多発性軟骨炎の全国疫学調査. リウマチ科 44 : 381-383, 2010
 
4) Trentham DE, Le CH : Relapsing polychondritis. Ann Intern Med 129 : 114-122, 1998
PubMed
5) Letko E, Zafirakis P, Baltatzis S, et al : Relapsing polychondritis : a clinical review. Semin Arthritis Rheum 31 : 384-395, 2002
PubMed
6) Vitale A, Sota J, Rigante D, et al : Relapsing polychondritis : an update on pathogenesis, clinical features, diagnostic tools, and therapeutic perspectives. Curr Rheumatol Rep 18 : 3, 2016
PubMed
7) Damiani JM, Levine HL : Relapsing polychondritis-report of ten cases. Laryngoscope 89 : 929-946, 1979
PubMed
8) Michet CJ Jr, McKenna CH, Luthra HS, et al : Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 104 : 74-78, 1986
PubMed
9) Papo T, Wechsler B, Bletry O, et al : Pregnancy in relapsing polychondritis : twenty-five pregnancies in eleven patients. Arthritis Rheum 40 : 1245-1249, 1997
PubMed
10) Dion J, Costedoat-Chalumeau N, Sene D, et al : Relapsing polychondritis can be characterized by three different clinical phenotypes : analysis of a recent series of 142 patients. Arthritis Rheumatol 68 : 2992-3001, 2016
PubMed
11) Behar JV, Choi YW, Hartman TA, et al : Relapsing polychondritis affecting the lower respiratory tract. AJR Am J Roentgenol 178 : 173-177, 2002
PubMed
12) Lee KS, Ernst A, Trentham DE, et al : Relapsing polychondritis : prevalence of expiratory CT airway abnormalities. Radiology 240 : 565-573, 2006
PubMed
13) Ernst A, Rafeq S, Boiselle P, et al : Relapsing polychondritis and airway involvement. Chest 135 : 1024-1030, 2009
PubMed
14) Borgia F, Giuffrida R, Guarneri F, et al : Relapsing polychondritis : an updated review. Biomedicines 6 : 84, 2018
 
15) de Montmollin N, Dusser D, Lorut C, et al : Tracheobronchial involvement of relapsing polychondritis. Autoimmun Rev 18 : 102353, 2019
PubMed
16) Arnaud L, Mathian A, Haroche J, et al Pathogenesis of relapsing polychondritis : a 2013 update. Autoimmun Rev 13 : 90-95, 2014
PubMed
P.227 掲載の参考文献
1) Fox JR, Clerf LH : Broncholithiasis : report of ten case. Ann Intern Med 23 : 955-959, 1945
 
2) 中島篤巳, 桑原修, 田中英之他 : 気管支結石症-3 手術例の病理学的, 臨床的検討. 日胸疾会誌 16 : 781-786, 1978
 
3) Alshabani K, Ghosh S, Arrossi AV, et al : Broncholithiasis. Chest 156 : 445-455, 2019
PubMed
4) 木下康民, 荻間勇, 山崎雅司他 : 頻回の喀血と中葉症候群を伴った気管支結石症の1例. 内科 20 : 541-546, 1967
 
5) 小沢克良, 広瀬芳樹, 福島雅夫他 : 気管支結石症 : 4 症例の報告と文献的考察. 日気食会報 30 : 331-338, 1979
 
6) Weed LA, Anderson HA : Etiology of broncholithiasis. Dis Chest 37 : 270-277, 1960
 
7) 朝川勝明, 島田昌裕, 蛇澤晶他 : 気管支結石症. 日胸 71 (別冊) : S291-S295, 2012
 
8) 平島智徳, 大畑一郎, 玉野井優水他 : 粘液貯留に起因する多発性の気管支結石の1例. 日胸疾会誌 31 : 79-83, 1993
 
9) Kennedy MP, Noone PG, Carson J, et al : Calcium stone lithoptysis in primary ciliary dyskinesia. Respir Med 101 : 76-83, 2007
PubMed
10) 下田清美, 中川隆行, 平松美也子他 : 気支結石症に喀血に対して肺葉切除術を行った粟粒結核症の1例. 気管支学 37 : 393-398, 2015
 
11) 蛇澤晶, 朝川勝明, 田村厚久他 : Mycobacterium avium complex症の病理. 日胸 68 : 1032-1045, 2009
Medical*Online
12) Seo JB, Song KS, Lee JS, et al : Broncholithiasis : review of the causes with radiologic-pathologic correlation. RaidoGraphics 22 : S199-213, 2002
PubMed
13) 石井芳樹, 北村諭, 遠山信幸他 : 成因を異にする気管支結石症の2例. 気管支学 11 : 597-603, 1989
 
14) Lim SY, Lee KJ, Jeon K, et al : Classification of broncholith and clinical outcomes. Respirology 18 : 637-642, 2013
 
15) 宮本牧, 西村和幸, 松本卓子他 : 放線菌感染を合併した末梢肺結核性被包乾酪巣由来の気管支結石症の1例. 日呼吸会誌 46 : 627-633, 2008
Medical*Online
16) Kim TS, Ham J, Koh WJ, et al : Endobronchial actinomycosis associated with broncholithiasis : CT findings for nine patients. AJR 185 : 347-353, 2005
 
P.233 掲載の参考文献
1) 日本循環器学会, 日本肺高血圧・肺循環学会, 日本呼吸器学会他 : 肺高血圧症治療ガイドライン (2017年改訂版). https://www.j-circ.or.jp/cms/wp-content/uploads/2020/02/JCS2017_fukuda_h.pdf (2021年10月閲覧)
 
2) Simonneau G, Montani D, Celermajer DS, et al : Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53 : 1801913, 2019
PubMed
3) Pietra GG, Capron F, Stewart S, et al : Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43 : 25S-32S, 2004
PubMed
4) Humbert M, Guignabert C, Bonnet S, et al : Pathology and pathobiology of pulmonary hypertension : state of the art and research perspectives. Eur Respir J 53 : 1801887, 2019
PubMed
5) Heath D, Edwards JE : The pathology of hypertensive pulmonary vascular disease : A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18 : 533-547, 1958
PubMed
6) Yaginuma G, Mohri H, Takahashi T : Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease : a computer aided reconstruction study. Thorax 45 : 586-590, 1990
PubMed
7) 日本肺高血圧・肺循環学会 : PVOD (肺静脈閉塞症) PCH (肺毛細血管腫症) 診療ガイドライン. 2017
 
P.238 掲載の参考文献
1) 日本肺高血圧・肺循環学会 : 慢性血栓塞栓性肺高血圧症 (CTEPH) 診療ガイドライン. 2018. http://jpcphs.org/pdf/guideline/cteph_guideline.pdf
 
2) 日本循環器学会, 日本肺高血圧・肺循環学会, 日本呼吸器学会他 : 肺高血圧症治療ガイドライン (2017年改訂版). http://j-circ.or.jp/guideline/pdf/JCS2017_fukuda_h.pdf (2021年10月閲覧)
 
3) Kim NH, Delcroix M, Jais X, et al : Chronic thromboembolic pulmonary hypertension. Eur Respir J 53 : 1801915, 2019
PubMed
4) Pengo V, Lensing AW, Prins MH, et al : Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 350 : 2257-2264, 2004
PubMed
5) Tanabe N, Sugiura T, Tatsumi K : Recent progress in the diagnosis and management of chronic thromboembolic pulmonary hypertension. Respir Investig 51 : 134-146, 2013
PubMed
6) Pepke-Zaba J, Delcroix M, Lang I, et al : Chronic thromboembolic pulmonary hypertension (CTEPH) : results from an international prospective registry. Circulation 124 : 1973-1981, 2011
PubMed
7) Tanabe N, Kimura A, Amano S, et al : Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 25 : 131-138, 2005
PubMed
8) Ogo T, Fukuda T, Tsuji A, et al : Efficacy and safety of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension guided by cone-beam computed tomography and electrocardiogram-gated area detector computed tomography. Eur J Radiol 89 : 270-276, 2017
PubMed
9) Hosokawa K, Ishibashi-Ueda H, Kishi T, et al : Histopathological multiple recanalized lesion is critical element of outcome after pulmonary thrombo-endarterectomy. Int Heart J 52 : 377-381, 2011
 
10) Orell SR, Hultgren S : Anastomoses between bronchial and pulmonary arteries in pulmonary thromboembolic disease. Acta Pathol Microbiol Scand 67 : 322-338, 1966
PubMed
11) Dorfmuller P, Gunther S, Ghigna MR, et al : Microvascular disease in chronic thromboembolic pulmonary hypertension : a role for pulmonary veins and systemic vasculature. Eur Rospir J 44 : 1275-1288, 2014
PubMed
12) Jujo T, Sakao S, Ishibashi-Ueda H, et al : Evaluation of the microcirculation in chronic thromboembolic pulmonary hypertension patients : The impact of pulmonary arterial remodeling on postoperative and follow-up pulmonary arterial pressure and vascular resistance. PLoS One 10 : e0133167, 2015
 
P.243 掲載の参考文献
1) von Herbay A, Illes A, Waldherr R, et al : Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 66 : 587-592, 1990
PubMed
2) Uruga H, Fujii T, Kurosaki A, et al : Pulmonary tumor thrombotic microangiopathy : a clinical analysis of 30 autopsy cases. Intern Med 52 : 1317-1323, 2013
PubMed
3) Godbole RH, Saggar R, Kamangar N : Pulmonary tumor thrombotic microangiopathy : a systematic review. Pulm Circ 9 : 1-13, 2019
PubMed
P.247 掲載の参考文献
1) Simonneau G, Montani D, Celermajer DS, et al : Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53 : 1801913, 2019
PubMed
2) 日本循環器学会, 日本肺高血圧・肺循環学会, 日本呼吸器学会他 : 肺高血圧症治療ガイドライン (2017年改訂版). http://j-circ.or.jp/guideline/pdf/JCS2017_fukuda_h.pdf (2022年1月閲覧)
 
3) Vachiery JL, Tedford RJ, Rosenkranz S, et al : Pulmonary hypertension due to left heart disease. Eur Respir J 53 : 1801897, 2019
PubMed
4) Grunberg K, Mooi WJ : Pulmonary vascular pathology. in Hasleton P, Flieder DB (eds) : Spencer's Pathology of the Lung, Cambridge University Press, Cambridge, 2013, pp661-710
 
5) Fayyaz AU, Edwards WD, Maleszewski JJ, et al : Global pulmonary vascular remodeling in pulmonary hypertension associated with heart failure and preserved or reduced ejection fraction. Circulation 137 : 1796-1810, 2017
PubMed
P.253 掲載の参考文献
1) Simonneau G, Gatzoulis, MA, Adatia I, et al : Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62 : D34-41, 2013
PubMed
2) 日本肺高血圧・肺循環学会編 : 肺静脈閉塞症 (PVOD) 肺毛細血管腫症 (PCH) 診療ガイドライン, 2017, http://www.jpcphs.org/pdf/guideline/guideline.pdf
 
3) Hora J : Zur Histologie der klinischen "primaren Pulmonalsklerose." Frankfurt Z Pathol 47 : 100-108, 1934
 
4) Heath D, Segel N, Bishop J : Pulmonary veno-occlusive disease. Circulation 34 : 242-248, 1966
PubMed
5) Brown CH, Harrison CV : Pulmonary veno-occlusive disease. Lancet 2 : 61-65, 1966
PubMed
6) Pietra GG, Edwards WD, Kay JM, et al : Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation 80 : 1198-1206, 1989
PubMed
7) Eyries M, Montani D, Girerd B, et al : EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet 46 : 65-69, 2014
PubMed
8) Best DH, Sumner KL, Austin ED, et al : EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest 145 : 231-236, 2014
PubMed
9) 大郷恵子, 植田初江, 大郷剛 : 肺動脈性肺高血圧症および肺静脈閉塞症/肺毛細血管腫症の病理-最近の知見から-. 日呼吸誌 3 : 471-477, 2014
 
10) 鈴木高明, 田部井史子, 関光里他 : Electrical Stormの治療に難渋し, その背景にPVODの関与が考えられた1例. 心臓 53 : 101-107, 2021
Medical*Online
11) Suzuki T, Hirose K, Tabei F, et al : An autopsy case of pulmonary veno-occlusive disease complicated with chronic obstructive pulmonary disease and severe pulmonary Hypertension. Int Heart J 62 : 1186-1190, 2021
PubMed
12) Saito A, Takizawa H, Ito K, et al : A case of veno-occlusive disease associated with systemic sclerosis. Raspirology 8 : 383-385, 2003
 
13) Wagenvoort CA, Beetstra A, Spijker J : Capillary haemangiomatosis of the lungs. Histopathology 2 : 401-406, 1978
PubMed
P.257 掲載の参考文献
1) 日本循環器学会他 : 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2017年改訂版). https://j-circ.or.jp/old/guideline/pdf/JCS2017_ito_h.pdf
 
2) Parker BM, Smith JR : Pulmonary embolism and infarction ; a review of the physiologic consequences of pulmonary arterial obstruction. Am J Med 24 : 402-427, 1958
PubMed
3) Tsao MS, Schraufnagel D, Wang NS : Pathogenesis of pulmonary infarction. Am J Med 72 : 599-606, 1982
PubMed
4) Stein M, Thomas D, Tanabe G, et al : Humoral factors in experimental pulmonary embolism. J Clin Invest 42 : 982, 1963
 
5) Miniati M, Prediletto R, Formichi B, et al : Accuracy of clinical assessment in the diagnosis of pulmonary embolism. Am J Respir Crit Care Med 159 : 864-871, 1999
PubMed
6) 長谷川浩一, 沢山俊民, 伊吹山千晴他 : 急性肺塞栓症の早期診断と治療対策-多施設225例の臨床的解析. 呼と循 41 : 773-777, 1993
 
7) 岡田修, 佐久間聖仁, 中村真潮他 : 肺血栓塞栓症急性型と慢性肺高血圧型の診断手技と臨床病態 肺塞栓症研究会共同作業部会報告. Ther Res 22 : 1481-1486, 2001
 
8) Butler J, Kowalski TF, Willoughly S, et al : Preventing infarctions after pulmonary artery occlusion. Clin Res 37 : 163A, 1989
 
9) Dalen JE, Haffajee CI, Alpert JS, et al : Pulmonary embolism, pulmonary hemorrhage and pulmonary infarction. N Engl J Med 296 : 1431-1435, 1977
PubMed
10) Schraufnagel DE, Tsao MS, Yao YT, et al : Factors associated with pulmonary infarction. A discriminant analysis study. Am J Clin Pathol 84 : 15-18, 1985
PubMed
P.263 掲載の参考文献
1) 日本結核病学会用語委員会 : 新しい結核用語辞典, 南江堂, 2008, p21.
 
2) Rasmussen V : On hemoptysis, especially when fatal, in its anatomical and clinical aspects, translated by Moore WD. Edinb Med J 15 : 385-401, 1869
 
3) Plessinger VA, Jolly PN : Rasmussen's aneurysms and fatal hemorrhage in pulmonary tuberculosis. Am Rev Tuberc 60 : 589-603, 1949
 
4) Harris P, Heath D : The Human Pulmonary Circulation (3rd ed), Churchill Livingstone, New York, 1986, pp596-604
 
5) Chung MJ, Lee JH, Lee KS, et al : Bronchial and nonbronchial systemic arteries in patients with hemoptysis : depiction on MDCT angiography. AJR Am J Roentgenol 186 : 649-655, 2006
PubMed
6) 石川秀雄, 蛇澤晶 : 喀血に対するカテーテル治療-気管支動脈塞栓術-. 日本気管食道科学会「専門医通信」 43 : 1-10, 2011
 
7) Stemmermann GN, Auerbach O : Massive pulmonary hemorrhage in tuberculosis : a report of two unusual cases. Am Rev Tuberc 62 : 324-330, 1950
PubMed
8) Thompson JR : Mechanisms of fatal pulmonary hemorrhage in tuberculosis. Dis Chest 25 : 193-205, 1954
PubMed
9) Liebow AA, Hales MR, Lindskog GE, et al : Enlargement of the bronchial arteries, and their anastomoses with the pulmonary arteries in bronchiectasis. Am J Path 25 : 211-231, 1949
PubMed
10) Savale L, Parrot A, Khalil A, et al : Cryptogenic hemoptysis. Am J Respir Crit Care Med 175 : 1181-1185, 2007
PubMed
11) Sweerts M, Nicholson AG, GoldstrawP, et al : Dieulafoy's disease of the bronchus. Multidiscip Respir Med 50 : 697-698, 1995
 
12) 禹哲漢, 田尻道彦, 植草利公他 : 特発性気管支動脈破裂の2例. 気管支学 29 : 227-231, 2007
Medical*Online
P.268 掲載の参考文献
1) Kussmaul A, Maier R : Ueber eine bisher nicht beschriebene eigenthumliche arterienerkrankung (periarteritis nodosa), die mit morbus brightii und rapid fortschreitender allgemeiner muskellahmung einhergeht. Deutsche Archiv Klinische Medizin 1 : 484-518, 1866
 
2) Ferrari E : Ueber polyarteritis acuta nodosa (sogenannte periar-teritis nodosa) und ihre beziehungen zur polymyositis und polyneuritis acuta. Beitr Pathol Anat Allg Pathol 34 : 350-386, 1903
 
3) Dickson WEC : Polyarteritis acuta nodosa and periarteritis nodosa. J Pathol Bact 12 : 31-57, 1908
 
4) Wohlwill F : Ueber die nur mikroskopisch erkennbare form der periarteriitis nodosa. Virchows Arch Pathol Anat 246 : 377-411, 1923
 
5) Davson J, Ball J, Platt R : The kidney in periarteritis nodosa. Q J Med 17 : 175-202, 1948
PubMed
6) Jennette JC, Falk RJ, Andrassy K, et al : Nomenclature of systemic vasculitides. Arthritis Rheum 37 : 187-192, 1994
PubMed
7) Jennette JC, Falk RJ, Bacon PA, et al : 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
8) 難治性血管炎の医療水準・患者QOL向上に資する研究班 : 結節性多発動脈炎. https://www.vas-mhlw.org/. Published 2021. Accessed 2021/05/05, 2021
 
9) 難治性血管炎の医療水準・患者QOL 向上に資する研究班 : 顕微鏡的多発血管炎. https://www.vas-mhlw.org/. Published 2021. Accessed 2021/05/05, 2021
 
10) 栗原泰 : 肺血管炎の画像診断 MPA. 臨床画像 33 : 1341-1345, 2017
 
11) Matsumoto T, Homma S, Okada M, et al : The lung in polyarteritis nodosa : a pathologic study of 10 cases. Hum Pathol 24 : 717-724, 1993
PubMed
12) Arkin A : A clinical and pathological study of periarteritis nodosa : A report of five cases, one histologically healed. Am J Pathol 6 : 401-426.405, 1930
 
13) 蛇澤晶, 倉持茂, 小倉高, 他 : MPO-ANCA陽性症例における慢性間質性肺炎の病理. 日本胸部臨床 67 : 210-219, 2008
 
14) Csernok E : Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2 : 158-164, 2003
PubMed
15) Kessenbrock K, Krumbholz M, Schonermarck U, et al : Netting neutrophils in autoimmune small-vessel vasculitis. Nature Medicine 15 : 623-625, 2009
PubMed
P.274 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al : Nomenclature of systemic vasculitides. Proposal of international consensus conference. Arthritis Rheum 37 : 187-192, 1994
PubMed
2) Jennette JC, Falk RJ, Bacon PA, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
3) 橋本博史 : Wegener肉芽腫症. 厚生労働省厚生科学特定疾患対策研究事業 難治性血管炎に関する調査研究班 : 難治性血管炎の診療マニュアル, 2002, pp30-34
 
4) Ono N, Niiro H, Ueda A, et al : Characteristics of MPOANCA-positive granulomatosis with polyangiitis : a retrospective multi-center study in Japan. Rheumatol Int 35 : 555-559, 2015
 
5) 日本循環器学会他 : 血管炎症候群の診療ガイドライン (2017年改訂版), 2018, pp60-65
 
6) Lee KS, Kim TS, Fujimoto K, et al : Thoracic manifestation of Wegener's granulomatosis : CT findings in 30 patients. Eur Radiol 13 : 43-51, 2003
 
7) Mark EJ, Matsubara O, Tan-Liu N, et al : The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis : A study based on 35 open lung biopsy. Hum Pathol 19 : 1065-1071, 1988
 
8) Travis WD, Hoffman GS, Leavitt RY, et al : Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol 15 : 315-333, 1991
 
9) Katzenstein AL, Locke WK : Solitary lung lesions in Wegener's granulomatosis. Pathologic findings and clinical significance in 25 cases. Am J Surg Pathol 19 : 542-552, 1995
 
10) Mark EJ, Flieder DB, Matsubara O, et al : Treated Wegener's granulomatosis : distinctive pathological findings in the lungs of 20 patients and what they tell us about the natural history of the disease. Hum Pathol 28 : 450-458, 1997
 
11) Yousem SA : Bronchocentric injury in Wegener's granulomatosis : A report of five cases : Hum Pathol 22 : 535-540, 1991
 
12) Travis WD, Leslie KO, Beasley MB : Pulmonary vasculitis and pulmonary hemorrhage. in Leslie KO, Wick MR (eds) : Practical Pulmonary Pathology : A Diagnostic Approach (3rd ed), Elsevier, Philadelphia, 2018, pp367-377
 
13) Uner AH, Rozum-Slota B, Katzenstein AL : Bronchiolitis obliterans-organizing pneumonia (BOOP) -like variant of Wegener's granulomatosis. A clinicopathologic study of 16 cases. Am J Surg Pathol 20 : 794-801, 1996
 
14) Csernok E : Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides. Autoimmun Rev 2 : 158-164, 2003
PubMed
15) Heckmann M, Holle JU, Arning L, et al : The Wegener's granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping. Ann Rheum Dis 67 : 972-979, 2008
 
P.279 掲載の参考文献
1) Churg J, Strauss L : Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 27 : 277-301, 1951
PubMed
2) Jennette JC, Falk RJ, Andrassy K, et al : Nomenclature of systemic vasculitides : the proposal of an international consensus conference. Arthritis Rheum 37 : 187-192, 1994.
PubMed
3) Cohen-Tervaert JW, Limburg PC, Elema JD, et al : Detection of autoantibodies against myeloid lysosomal enzymes : a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. Am J Med 91 : 59-66, 1991
 
4) Jennette JC, Falk RJ, Bacon PA, et al : 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
5) Churg A : Recent advances in the diagnosis of Churg-Strauss syndrome. Mod Pathol 14 : 1284-1293, 2001
 
6) Sinico RA, Di Toma L, Maggiore U, et al : Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52 : 2926-2935, 2005
PubMed
7) Cottin V, Bel E, Bottero P, et al : Respiratory manifestation of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Eur Respir J 48 : 1429-1441, 2016
PubMed
8) Grayson PC, Ponte C, Suppiah R, et al : 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Arthritis Rheum. doi : 10.1002/art.41982, 2022
 
9) 難病情報センター : 好酸球性多発血管炎性肉芽腫症. https://www.nanbyou.or.jp/
 
10) 福富友馬, 谷口正実, 粒来崇博他 : 本邦における病院通院成人喘息患者の実態調査-国立病院機構ネットワーク共同研究. アレルギー 59 : 37-46, 2010
 
11) Sada KE, Amano K, Uehara R, et al : A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan. Mod Rheumatol 24 : 640-644, 2014
 
12) 谷口正実, 関谷潔史, 上出庸介他 : 好酸球性多発血管炎性肉芽腫症. アレルギー 69 : 293-302, 2020
Medical*Online
13) Kim YK, Lee KS, Chung MP, et al : Pulmonary involvement in Churg-Strauss syndrome : an analysis of CT, clinical, and pathologic findings. Eur Radiol 17 : 3157-3165, 2007
PubMed
14) Silva CIS, Muller NL, Fujimoto K, et al : Churg-Strauss syndrome. Hight resolution CT nad pathologic findings. J Thorc Imaging 20 : 74-80, 2005
 
15) Mark EJ, Smith RN, Stone JH : Pulmonary vasculitis and pulmonary hemorrhage syndromes. in Hasleton P, Flieder DB (ed) : Spencer's pathology of the lung (6th ed), Cambridge University Press, Cambridge, 2013, pp711-766
 
P.283 掲載の参考文献
1) 日本循環器学会他 : 血管炎症候群の診療ガイドライン (2017年改訂版), 2018 http://www.j-circ.or.jp/guideline/pdf/JCS2017_isobe_h.pdf
 
2) Jennette JC, Falk RJ, Bacon PA, et al : 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
3) 難病情報センター : 特定疾患医療受給者証所持者数 http://www.nanbyou.or.jp/entry/1356
 
4) Watanabe Y, Miyata T, Tanemoto K : Current clinical features of new patients with Takayasu arteritis from crosscountry research in Japan age and sex specificity. Circulation 132 : 1701-1709, 2015
 
5) Isohisa I, Numano F, Maezawa H, et al : HLA-Bw52 in Takayasu disease. Tissue Antigens 12 : 246-248, 1978
PubMed
6) 斎藤健 : 大動脈炎症候群 (高安動脈炎)の肺病変について. 日胸 47 : 655-665, 1988
 
7) 後藤慎平 : 肺高血圧症と肺血管疾患. 蝶名林直彦監修 : 肺HRCT (原書4版), 2010, pp597-626
 
8) Saha BK, Burns SL, Foulke LA, et al : Coexistent Takayasu arteritis and sarcoidosis : a case report and review of the literature. Sarcoidosis Vasc Diffuse Lung Dis 36 : 311-317, 2019
PubMed
P.287 掲載の参考文献
1) Jennette JC, Falk RJ, Bacon PA, et al : 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013
 
2) 高橋啓, 大原関利章, 横内幸他 : 血管炎の新しい分類 : 2012 Revised International Chapel Hill Consensus Conference Nomencrature of Vasculitides (CHCC2012). 日腎会誌 56 : 70-79, 2014
 
3) Wieslander J, Barr JF, Butkowski RJ, et al : Goodpasture antigen of the glomerular basement membrane : Localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci U S A 81 : 3838-3842, 1984
PubMed
4) Hudson BG, Tryggvason K, Sundaramoothy M, et al : Mechanisms of disease : Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348 : 2543-2556, 2003
 
5) Pedchenko V, Bondar O, Fogo AB, et al : Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363 : 343-354, 2010
PubMed
6) Tang W, McDonald SP, Hawley CM, et al. Anti-glomerular basement membrane antidoby disease is an uncommon cause of end-stage renal disease. Kidney Int 83 : 503-510, 2013
 
7) Greco A, Rizzo M, Virgilio AD, et al : Goodpasture's syndrome : A clinical update. Autoimmun Rev 14 : 246-253, 2015
 
8) 厚生労働省特定疾患進行性腎障害に関する調査研究班 : 急速進行性腎炎症候群の診療指針, 第2版. 日腎会誌 53 : 509-555, 2011
 
9) Hellmark T, Segelmark M : Diagnosis and classification of Goodpasture's disease (anti-GBM). J Autoimmun 48-49 : 108-112, 2014
 
10) Nagashima T, Ubara Y, Tagami T, et al : Anti-glomerular basement membrane antibody disease : a case report and a review of Japanese patients with and without alveolar hemorrhage. Clin Exp Nephrol 6 : 49-57, 2002
 
11) Cui Z, Zhao MH : Advances in human antiglomerular basement membrane disease. Nat Rev Nephrol 7 : 697-705, 2011
PubMed
12) Sinico RA, Radice A, Corace C, et al : Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome : a comparison of different assay. Nephrol Dial Transplant 21 : 397-401, 2006
 
13) 清水章 : 抗GBM病. 日本腎病理協会/日本腎臓学会編 : 腎生検病理アトラス 改訂版, 東京医学社, 2017, pp126-131
 
14) Mark EJ, Smith RN, Stone JH, et al : Pulmonary vasculitis and pulmonary hemorrhage syndromes. in Hasleton P, Fielder DB (ed) : Spencer's Pathlogy of the Lung (6th ed), Cambridge University Press, New York, 2013, pp711-766
 
15) Thongprayoon C, Kaewput W, Boonpheng B, et al : Impact of ANCA-associated vasculitis on outcomes of hospitalizations for Goodpasture's syndrome in the United States : Nationwide inpatient sample 2003-2014. Medicina 56 : 103, 2020
 
16) Olson SW, Arbogast CB, Baker TP, et al : Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol 22 : 1946-1952, 2011
PubMed
17) McCall AS, Bhave G, Pedchenko V, et al : Inhibitory antiperoxidasin antibodies in pulmonary-renal syndromes. J Am Soc Nephrol 29 : 2619-2625, 2018
PubMed
P.296 掲載の参考文献
1) Sporn T, Roggli VL : Occupational lung disease, Chapter 14. in Hasleton P, Flieder DB (eds) : Spencer's Pathology of the Lung, vol.1 (6th ed), Cambridge University Press, Cambridge, 2013, pp512-525
 
2) Churg AM, Green FHY : Occupational lung disease, Chapter 24. in Churg A, Myers JL, Tazelaar HD, et al (eds) : Thurlbeck's Pathology of the Lung (3rd ed), Thieme, New York, 2005, pp810-829
 
3) 山中晃, 斉木茂樹, 岡本賢三 : 呼吸細気管支領域の特殊性とその病変のなり立ち. 日本臨牀 36 : 2427-2433, 1978
Medical*Online
4) 本間浩一 : 石綿肺を中心とした非腫瘍性肺胸膜病変の病理. 日本胸部臨床 65 : 425-438, 2006
Medical*Online
5) Ndlovu N, Rees D, Murray J, et al : Asbestos-related diseases in mineworkers : a clinicopathological study. ERJ Open Res 3 : 00022-2017, 2017
PubMed
6) Kishimoto T, Kato K, Arakawa H, et al : Clinical, radiological, and pathological investigation of asbestosis. Int J Environ Res Public Health 8 : 899-912, 2011
PubMed
7) Akira M, Yamamoto S, Inoue Y, et al : High-resolution CT of asbestosis and idiopathic pulmonary fibrosis. AJR Am J Roentgenol 181 : 163-169, 2003
PubMed
8) Arakawa H, Kishimoto T, Ashizawa K, et al : Asbestosis and other pulmonary fibrosis in asbestos-exposed workers : high-resolution CT features with pathological correlations. Eur Radiol 26 : 1485-1492, 2016
PubMed
9) Sporn TA, Roggli VL : Asbestosis, Chaper 4. in Roggli VL, Oury TD (eds) : Pathology of Asbestos-associated Diseases (2nd ed), Springer-Verlag, New York, 2004, pp71-103
 
10) Craighead JE, Abraham JL, Churg A, et al : The pathology of asbestos-associated diseases of the lung and pleural cavities : Diagnostic criteria and proposed grading schema. Arch Pathol Lab Med 106 : 544-596, 1982
PubMed
11) American Thoracic Society : The diagnosis of non-malignant disease rerated to asbestos. Am Rev Respir Dis 134 : 363-368, 1986
 
12) Henderson DW, Rantanen J, Barnhart S, et al : Asbestos, asbestosis and cancer : the Helsinki criteria for diagnosis and attribution. A consensus report of an international expert group. Scand J Work Environ Health 23 : 311-316, 1997
 
13) American Thoracic Society : Diagnosis and initial management of nonmalignant disease related to asbestos. Am J Respir Crit Care Med 170 : 691-715, 2004
PubMed
14) Roggli VL, Gibbs AR, Attanoos R, et al : Pathology of asbestosis-an update of the diagnostic criteria. report of the asbestosis committee of the College of American Pathologists and Pulmonary Pathology Society. Arch Pathol Lab Med 134 : 462-480, 2010
PubMed
15) 岸本卓巳 : アスベスト肺の診断. 日内会誌 96 : 2032-2038, 2007
 
16) 岡本賢三 : 石綿肺の病理学的特徴. 井内康輝編 : 石綿関連疾患の病理とそのリスクコミュニケーション, 篠原出版新社, 2015, pp130-142
 
P.301 掲載の参考文献
1) Nagelshimidt G : The relation between lung dust and lung pathology in pneumoconiosis. Brit J Industr Med 17 : 247, 1960
 
2) Yates DH, Johnson AR : Silicosis and other silica-related lung disorders. in Feary J, Suojalehto HM, Cullinan P (eds) : Occupational and Environmental Lung Disease, ERS Monograph, UK, 2020, pp150-175
 
3) Hoy RF, Chambers DC : Silica-related disease in the modern world. Allergy 75 : 2805-2817, 2020
PubMed
4) Well H, Jones R, Parkes WR : Silicosis and related diseases in Parkes WR (ed) : Occupational Lung Disorders (3rd ed), Butterworth-Heinemann, Oxford, 1994, pp 285-339
 
5) Hutyrova B, Smolkova P, Nakladalova M, et al : Case of accelerated silicosis in a sandblaster. Industrial Health 53 : 178-183, 2015
 
6) Levin K, Mclean C, Hoy R : Artificial stone-associated silicosis : clinical-pathological-radiological correlates of disease. Respir Case Rep 7 : e00470, 2019
 
7) Honma K, Abraham JL, Chiyotani K, et al : Proposed criteria for mixed-dust pneumoconiosis : Definition, descriptions, and guidelines for pathologic diagnosis and clinical correlation. Hum Pathol 35 : 1515-1523, 2004
PubMed
8) Alvarez RF, Gonzalez CM, Martinez AQ, et al : Guidelines for the diagnosis and monitoring of silicosis. Arch Bronchopneumol 51 : 86-93, 2015
 
9) 中野郁夫, 木村清延, 田上清一他 : 北海道の歯科技工士じん肺に関する疫学調査. 日職災医誌 53 : 112-116, 2005
 
10) Hoy RF, Baird T, Hammerschlag G, et al : Artificial stone-associated silicosis : a rapidly emerging occupational lung disease. Occup Envirn Med 75 : 3-5, 2018
 
11) 厚生労働省労働基準局編 : 業務上疾病の労災補償状況調査結果 (令和元年度).
 
12) International Agency for Research on Cancer : IARC Monographs on the Evaluation of the Carcinogeneic Risk of Chemicals to Humans, Volume 68, Silica, Some Silicates, Coal Dust and para-Aramid Fibrils, IARC, Lyon, 1997
 
13) Katabami M, Dosaka-Akita H, Honma K, et al : Pneumoconiosis-related lung cancers. Am J Respir Crit Care Med 162 : 295-300, 2000
PubMed
14) Sato T, Shimosato T, Kinman DM : Silicosis and lung cancer : current perspective. Lung Cancer 9 : 91-101, 2018
 
15) 大塚義紀, 宇佐美郁治, 水橋啓一他 : じん肺患者における好中球細胞質抗体 (ANCA) 陽性率の検討-多施設共同横断的研究-. 日職災医誌 66 : 196-200, 2018
 
16) Shida H, Chiyotani K, Honma K, et al : Radiologic and pathologic characteristics of mixed dust pneumoconiosis. Radiographics 16 : 483-498, 1996
PubMed
17) 大塚義紀, 加藤勝也, 芦澤和人他 : じん肺における間質性肺病変の種類と頻度. 日職災医誌 69 : 267-273, 2021
 
18) Arakawa H, Johkoh T, Honma K, et al : Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis. Chest 131 : 1870-1876, 2007
PubMed
19) 岡本賢三 : 職業性肺疾患. 病理と臨床 32 : 1117-1126, 2014
Medical*Online
20) Kambouchner M, Bernaudin JF : The pathologist's view of silicosis in 1930 and in 2015. The Johannesburg Conference Legacy. Am J Indust Med 58 : S48-58, 2015
 
21) 本間浩一, 千代谷慶三 : 塵肺症の病理形態学-珪肺症を中心として-. 呼吸 11 : 914-919, 1992
Medical*Online
22) Adamcakova J, Mokra D : New Insights into pathomechanisms and treatment possibilities for lung silicosis. Int J Mol Sci 22 : 4162, 2021
PubMed
23) Cheepsattayakorn A, Ceepsattayakorn R : Silicosis : Pathogenesis and biomarkers. Ann Clin Pathol 6 : 1147, 2018
 
P.308 掲載の参考文献
1) Bech AO, Kipling MD, Heather JC : Hard metal lung disease. Br J Ind Med 19 : 239-252, 1962
 
2) Ohori NP, Sciurba FC, Owens GR, et al : Giant-cell interstitial pneumonia and hard-metal pneumoconiosis. Am J Surg Pathol 13 : 581-587, 1989
PubMed
3) Demedts M, Gheysens B, Nagels J, et al : Cobalt lung in diamond polishers. Am Rev Respir Dis 130 : 130-135, 1984
PubMed
4) Jobs H, Ballhausen C : Metallkeramik als Staubquelle vom arztlichen und technischen Standpunkt. Vertrauensarzt und Krankenkasse 8 : 142-148, 1940
 
5) 日下幸則, 杉本寛治, 関幸雄他. 超硬合金粉じんによる気管支肺疾患. 産業医学 24 : 636-648, 1982.
 
6) Davison AG, Haslam PL, Corrin B, et al : Interstitial lung disease and asthma in hard-metal workers : bronchoalveolar lavage, ultrastructural, and analytical findings and results of bronchial provocation test. Thorax 38 : 119-128, 1983
PubMed
7) Liebow AA, Carrington CB : The interstitial pneumonias. in Simon M (ed) : Frontiers of Pulmonary Radiology, Grune and Stratton, New York, 1969, pp102-141
 
8) Abraham JL : Lung pathology in 22 cases of giant cell interstitial pneumonia (GIP) suggests GIP is pathognomonic of cobalt (hard metal) disease. Chest 91 : 312, 1987
 
9) Paris C, Parion JC, Billon-Galland MA, et al : Giant cell interstitial pneumonia : Report of two cases with high titanium concentration in the lung. Am J Respir Crit Care Med 184 : 1315-1317, 2011
 
10) Eliott DRF, Shah R, Hess CA, et al : Giant cell interstitial pneumonia secondary to cobalt exposure from e-cigarette use. Eur Respir J 54 : 1901922, 2019
 
11) 石田卓士, 佐藤瑞穂, 寺田正樹他 : DPBとして治療されていたドリル研磨業の事務職員にみられた超硬合金肺の1例. Ther Res 21 : 1871-1875, 2000
Medical*Online
12) Tanaka J, Moriyama H, Terada M, et al : An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease. BMJ Open 4 : e004407, 2014
PubMed
13) Akira M : Uncommon pneumoconiosis : CT and pathologic findings. Radiology 197 : 403-409, 1995
PubMed
14) Lison D, Lauwerys R, Demedts M, Nemery B : Experimental research into pathogenesis of cobalts/hard metal lung disease. Eur Resp J 9 : 1024-1028, 1996
 
15) Moriyama H, Kobayashi M, Takada T, et al : Two-dimentional analysis of elements and mononuclear cells in hard metal lung disease. Am J Resp Crit Care Med 176 : 70-77, 2007
 
16) Milde R, Ritter J, Tennent GA, et al : Multinucleated giant cells are specialized for complement-mediated phagocytosis and large target destruction. Cell Reports 13 : 1937-1948, 2015
PubMed
17) Nemery B, Abraham JL : Hard metal lung disease. Still hard to understand. Am J Respir Crit Care Med 176 : 2-3, 2007
PubMed
P.315 掲載の参考文献
1) 厚生労働省 : 2019年人口動態統計月報年計 (概数)の概況 (https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai19/dl/gaikyouR1.pdf)
 
2) 日本呼吸器学会 : 成人肺炎診療ガイドライン 2017. 日本呼吸器学会, 2017
 
3) 山中晃 : 肺の病変 (肺炎, その他). 横山武, 他編 : 現代の病理学 各論, 第1版, 金原出版, 1980, pp164-168
 
4) 森本浩之輔, 鈴木基, 石藤智子, 他 : 成人肺炎球菌性肺炎の疫学. IASR 35 : 238-239, 2014
 
5) Bradley SF : Staphylococcus aureus pneumonia : emergence of MRSA in the community. Semin Respir Crit Care Med 26 : 643-649, 2005
PubMed
6) Rubinstein E, Kollef MH, Nathwani D : Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46 : S378-S385, 2008
PubMed
7) Yildiz O, Doganay M : Actinomycoses and Nocardia pulmonary infections. Curr Opin Pulm Med 12 : 228-234, 2006
PubMed
8) 塚平晃弘, 大久保喜雄, 小林孝至, 他 : Klebsiella肺炎4例の画像的検討. 日呼吸会誌 40 : 530-535, 2002
Medical*Online
9) Lyczak JB, Cannon CL, Pier GB : Establishment of Pseudomonas aeruginosa infection : lessons from a versatile opportunist. Microbes Infect 2 : 1051-1060, 2000
PubMed
10) Sharma L, Losier A, Tolbert T, et al : Atypical pneumonia : Updates on Legionella, Chlamydophila, and Mycoplasma pneumonia. Clin Chest Med 38 : 45-58, 2017
PubMed
11) Dickson RP, Erb-Downward JR, Huffnagle GB : The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7 : 245-257, 2013
PubMed
12) Segal LN, Rom WN, Weiden MD : Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 11 : 108-116, 2014
PubMed
13) Dickson RP, Erb-Downward JR, Martinez FJ, et al : The microbiome and the respiratory tract. Annu Rev Physiol 78 : 481-504, 2016
PubMed
14) Huffnagle GB, Dickson RP, Lukacs NW : The respiratory tract microbiome and lung inflammation : a two-way street. Mucosal Immunol 10 : 299-306, 2017
PubMed
15) Wu BG, Segal LN : The lung microbiome and its role in pneumonia. Clin Chest Med 39 : 677-689, 2018
PubMed
P.323 掲載の参考文献
1) 蛇沢晶, 木谷匡志, 清水宏繁他 : 結核症と非結核性抗酸菌症. 病理と臨床 36 (増刊号) : 170-178, 2018
 
2) 清水重喜 : 感染性肉芽腫性疾患. 病理と臨床 32 : 1134-1140, 2014
Medical*Online
3) 蛇沢晶, 安田公彦, 馬場基男他 : 結核症の病理. 病理と臨床 21 (増刊号) : 178-185, 2003
 
4) 14回肺病理講習会テキスト, 2011, 熊谷, 2011
 
5) 森下宗彦, 渡辺彰編 : 結核ハンドブック, アトムス, 2014
 
6) 四元秀毅, 倉島篤行, 永井英明編 : 結核Up to Date, 改訂第4版, 南江堂, 2019
 
7) Sood A, Sreedhar R, Kulkarni P, et al : Hypersensitivity pneumonitis-like granulomatous lung disease with nontuberculous mycobacteria from exposure to hot water aerosols. Environ Health Perspect 115 : 262-266, 2017
 
8) Araya J, Kawabata Y, Tomichi N, et al : Allergic inflammatory reaction is involved in necrosis of human pulmonary dirofilariasis. Histopathology 51 : 484-490, 2007
PubMed
9) 堤寛 : 感染症アトラス, 文光堂, 2000, pp114-116
 
10) Bosken CH, Myers JL, Greenberger PA, et al : Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 12 : 216-222, 1988
PubMed
11) Hartel PH, Shilo K, Klassen-Fischer M, et al : Granulomatous reaction to Pneumocystis jirovecii : clinicopathologic review of 20 cases. Am J Surg Pathol 34 : 730-734, 2010
PubMed
12) Cicenas S, Vencevicius V : Lung cancer in patients with tuberculosis. World J Surg Oncol 5 : 22, 2007
PubMed
P.332 掲載の参考文献
1) Hinson KFW, Moon AJ, Plummer NS : Bronchopulmonary aspergillosis. Thorax 7 : 317-334, 1952
 
2) Perrone G, Gallo A : Aspergillus species and their associated mycotoxins. Methods Mol Biol 154 : 33-39, 2017
 
3) Fraser RS : Pulmonary aspergillosis : pathologic and pathogenetic features. Pathol Ann 28 (part 1) : 231-277, 1993
 
4) 蛇澤晶 : 腐生性肺アスペルギルス症の病理-喀血源を含めて. 日胸 62 : 1070-1080, 2003
 
5) 米田良蔵 : 菌球型肺アスペルギルス症. 日本臨牀 38 : 4343-4348, 1980
Medical*Online
6) Kamei K, Unno H, Nagao K, et al : Allergic bronchopulmonary mycosis caused by the Basidiomycetous fungus Schizophyllum commune. Clin Infect Dis 18 : 305-309, 1994
PubMed
7) Chowdhary A, Agarwal K, Kathuria S, et al : Allergic bronchopulmonary mycosis due to fungi other than Aspergillus : a global overview. Crit Rev Microbiol 40 : 30-48, 2014
PubMed
8) Katzenstein AL, Liebow AA, Friedman PJ : Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Resp Dis 111 : 497-537, 1975
PubMed
9) Jelihofsky T : The structure of bronchial plugs in mucoid impaction, bronchocentric granulomatosis and asthma. Histopathology 7 : 153-167, 1983
 
10) Bosken CH, Myers JL, Greenberger PA, et al : Pathologic features of allergic bronchopulmonary aspergillosis. Am J Surg Pathol 12 : 216-222, 1988
PubMed
11) 蛇沢晶, 田村厚久, 倉島篤行他 : 手術例からみたアレルギー性気管支肺アスペルギルス症・真菌症の病理形態学的研究. 日呼吸会誌 36 : 330-337, 1998
 
12) Scadding JG : The bronchi in allergic aspergillosis. Scand J Resp Dis 148 : 372-377, 1967
 
13) Rosenberg M, Patterson R, Mintzer R, et al : Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Int Med 86 : 405-414, 1977
 
14) Asano K, Hebisawa A, Ishiguro T, et al : New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol 147 : 1261-1268, 2021
PubMed
P.335 掲載の参考文献
1) Mulay SR, Anders HJ : Crystallopathies. N Engl J Med 374 : 2465-2476, 2016
PubMed
2) Ueki S, Miyabe Y, Yamamoto Y, et al : Charcot-Leyden crystals in eosinophilic inflammation : Active cytolysis leads to crystal formation. Curr Allergy Asthma Rep 19 : 35, 2019
 
3) Staribratova D, Belovejdov V, Staikov D, et al : Demonstration of Charcot-Leyden crystals in eosinophilic cystitis. Archives of pathology & laboratory medicine 134 : 1420, 2010
PubMed
4) Melo RCN, Wang H, Silva TP, et al : Galectin-10, the protein that forms Charcot-Leyden crystals, is not stored in granules but resides in the peripheral cytoplasm of human eosinophils. J Leukoc Biol 108 : 139-149, 2020
 
5) Ueki S, Tokunaga T, Melo RCN, et al : Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death. Blood 132 : 2183-2187, 2018
PubMed
6) Persson EK, Verstraete, K, Heyndrickx I, et al : Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science 364 : eaaw4295, 2019
PubMed
P.339 掲載の参考文献
1) Shinozaki M, Okubo Y, Sasai D, et al : Identification of Fusarium species in formalin-fixed and paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes. J Clin Microbiol 49 : 808-813, 2011
PubMed
2) 木村雅友 : 糸状菌感染症を中心とした病理診断と病態. 渋谷和俊, 久米光監修 : 深在性真菌症 病理診断アップデートレビュー, 協和企画, 2012, pp55-63
 
3) Nakamura Y, Utsumi Y, Suzuki N, et al : Multiple Scedosporium apiospermum abscesses in a woman survivor of a tsunami in northeastern Japan : a case report. J Med Case Rep 25 : 526, 2011
 
4) Tochigi N, Sadamoto S, Shinozaki M, et al : Comparison in quantities from including angles comprising lines of hypha themselves in histological images between Mucorales and Aspergillus. Med Mycol J 60 : 85-89, 2019
PubMed
5) 伊藤誠 : 酵母状真菌感染症の病理診断と病態. 渋谷和俊, 久米光監修 : 深在性真菌症 病理診断アップデートレビュー, 協和企画, 2012, pp33-54
 
6) Satoh K, Makimura K, Hasumi Y, et al : Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53 : 41-44, 2009
 
7) Sadamoto S, Shinozaki M, Nagi M, et al : Histopathological study on the prevalence of trichosporonosis in formalin-fixed and paraffin-embedded tissue autopsy sections by in situ hybridization with peptide nucleic acid probe. Med Mycol 58 : 460-468, 2020
 
P.347 掲載の参考文献
1) Guarner J, Brandt ME : Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev 24 : 247-280, 2011
PubMed
2) Kwon-Chung KJ, Bennett JE : Medical Mycology, Lea & Febiger, Philadelphia, 1992, pp464-513
 
3) Demkowicz R, Procop GW : Clinical significance and histologic characterization of Histoplasma granulomas. Am J Clin Pathol 155 : 581-587, 2020
 
4) Travis WD, Colby TV, Koss MN, et al : Histoplasma capsulatum. in King DW (ed) : Non-neoplastic Disorders of the Lower Respiratory Tract, ARP & AFIP, Washington DC, 2001, pp592-600
 
5) Donovan FM, Shubitz L, Powell D, et al. Early events in Coccidioidomycosis. Clin Microbiol Rev 33 : e00112-19, 2019
PubMed
6) Katzenstein ALA : Katzenstein and Askin's Surgical Pathology of Non-neoplastic Lung disease (4th ed), Saunders, Philadelphia, 2006, pp312-313
 
7) Travis WD, Colby TV, Koss MN, et al : Coccidioides immitis. in King DW (ed) : Non-neplastic Disorders of the Lower Respiratory Tract, ARP & AFIP, Washington DC, 2002, pp605-611
 
8) Stevens DA : Coccidioidomycosis. N Engl J Med 332 : 1077-1082, 1995
PubMed
9) Kirkland TN, Fierer J : Coccidioidomycosis : a reemerging infectious disease. Emerg Infect Dis 2 : 192-199, 1996
PubMed
10) Tuder RM, El Ibrahim R, Godoy CE, et al : Pathology of the human pulmonary paracoccidioidomycosis. Mycopathologia 92 : 179-188, 1985
PubMed
11) Poplin V, Smith C, Milsap D, et al : Diagnosis of pulmonary infections due to endemic fungi. Diagnostics 11 : 856, 2021
PubMed
12) Chander J : Paracoccidioidomycosis. in Textbook of Medical Mycology (4th ed), Jaypee Brothers Medical Publishers Ltd, New Delhi, 2018, pp379-397
 
13) Chander J : Talaromycosis. in Textbook of Medical Mycology (4th ed), Jaypee Brothers Medical Publishers Ltd, New Delhi, 2018, pp506-523
 
14) Milner D : Penicilliosis. in Milner D (ed) : Diagnostic Pathology : Infectious Diseases, Elsevier, Philadelphia, 2015, pp48-49
 
15) Vanittanakom N, Cooper CR Jr, Fisher MC, et al : Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 19 : 95-110, 2006
 
P.349 掲載の参考文献
1) 福地邦彦 : 各検査業務における感染対策の実践 6) 遺伝子・核酸検査. Medical Technology 43 : 1400-1404, 2015
Medical*Online
2) 若山恵, 定本聡太, 篠崎稔 : 感染症の病理学的側面 (病理学的感染症学概論) 微生物検査室で行われている同定の現状と進歩 切片上からの病原体同定方法. 病理と臨床 36 (臨増) : 104-108, 2018
 
3) Oliveira K, Haase G, Kurtzman C, et al : Differentiation of Candida albicans and Candida dubliniensis by fluorescent in situ hybridization with peptide nucleic acid probes. J Clin Mycrobiol 39 : 4138-4141, 2001
 
4) Shinozaki M, Okubo Y, Sasai D, et al : Identification of Fusarium species in formalin-fixed and paraffin-embedded sections by in situ hybridization using peptide nucleic acid probes. J Clin Mycrobiol 49 : 808-813, 2011
 
5) Shinozaki M, Okubo Y, Sasai D, et al : Development of a peptide nucleic acid probe to Trichosporon species and identification of trichosporonosis by use of in situ hybridization in formalin-fixed and paraffin-embedded (FFPE) sections. J Clin Microbiol 51 : 295-298, 2013
PubMed
6) Hanazawa R, Murayama SY, Yamaguchi H : In-situ detection of Aspergillus fumigatus. J Med Microbiol 49 : 285-290, 2000
PubMed
7) Neuveglise C, Sarfati J, Latge JP, et al : Afut1, a retrotransposon-like element from Aspergillus fumigatus. Nucleic Acid Research 24 : 1428-1434, 1996
PubMed
8) Shinozaki M, Tochigi N, Sadamoto S, et al : Histopathological diagnosis of invasive fungal infections in formalin-fixed and paraffin-embedded tissues in conjunction with molecular methods. Med Mycol J 59 : E7-E18, 2018
PubMed
9) Shinozaki M, Okubo Y, Sasai D, et al : Development and evaluation of nucleic acid-based techniques for an auxiliary diagnosis of invasive fungal infections in formalin-fixed and paraffin-embedded (FFPE) tissues. Med Mycol J 53 : 241-245, 2012
PubMed
10) Sadamoto S, Shinozaki M, Nagi M, et al : Histopathological study on the prevalence of trichosporonosis in formalin-fixed and paraffin-embedded tissue autopsy sections by in situ hybridization with peptide nucleic acid probe. Med Mycol 58 : 460-468, 2020
 
P.358 掲載の参考文献
1) 堤寛 : リケッチア症の病理. 病理と臨床 33 : 869-876, 2015
Medical*Online
2) 中島典子, 佐藤由子, 片野晴隆他 : ウイルス性肺炎. 病理と臨床 32 : 1146-1153,2014
Medical*Online
3) 佐多徹太郎, 佐藤由子, 中島典子 : ウイルス肺炎. 病理と臨床 23 : 516-527, 2005
Medical*Online
4) Katano H, Kano M, Nakamura T, et al : A novel realtime PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnosis. J Med Virol 83 : 322-330, 2011
 
5) Park JS, Jee YK, Lee KY, et al : Acute respiratory distress syndrome associated with Scrub Typhus : Diffuse alveolar damage without pulmonary vasculitis. J Korean Med Sci 15 : 343-345, 2000
PubMed
6) 中島典子 : 季節性および鳥インフルエンザウイルス感染症の病理. 病理と臨床 33 : 847-854, 2015
Medical*Online
7) 中島典子 : インフルエンザ, SARS, MERS. 病理と臨床 36 (臨時増刊号) : 324-330, 2018
 
8) 中島典子 : インフルエンザ感染症の病理. 小児内科 45 : 1935-1941, 2013
Medical*Online
9) 中島典子 : COVID-19, SARS, インフルエンザの肺病理. 病理と臨床 39 : 1216-1223, 2021
Medical*Online
10) Kuroda M, Katano H, Nakajima N, et al : Characterization of quasispecies of pandemic 2009 influenza A virus (A/H1N1/2009) by de novo sequencing using a next-generation DNA sequencer. PLoS One 23 : 1-9, 2010
 
11) Nakajima N, Hata S, Sato Y, et al : The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan : Detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis 63 : 67-71, 2010
PubMed
12) Nakajima N, Sato Y, Katano H, et al : Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection. Mod Pathol 25 : 1-13, 2012
PubMed
13) Kataoka M, Ishida K, Ogasawara K, et al : Serial section array scanning electron microscopy analysis of cells from lung autopsy specimens following fatal A/H1N1 2009 pandemic influenza virus infection. J Virol 93 : e00644-19, 2019
 
14) Liem NT, Nakajima N, Phat LP, et al : H5N1-infected cells in lung with diffuse alveolar damage in exdative phase from a fatal case in Vietnam. Jpn J Infect Dis 61 : 157-160, 2008
 
15) Nakajima N, Van TN, Sato Y, et al : Pathological study of archival lung tissues from five fatal cases of avian H5N1 influenza in Vietnam. Mod Pathol 26 : 357-369, 2010
 
16) 中島典子, 鈴木忠樹, 足立拓也他 : COVID-19. 病理と臨床 33 : 845-851, 2020
 
17) 佐多徹太郎, 永田典代, 中島典子他 : SARSウイルスとSARSの病理. 日本胸部臨床 62 : 796-803, 2003
Medical*Online
18) Nakajima N, Asahi-Ozaki Y, Nagata N, et al : SARS coronavirus-infected cells in lung detected by new in situ hybridization technique. Jpn J Infect Dis 56 : 139-141, 2003
PubMed
19) Adachi T, Chong JM, Nakajima N, et al : Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19, Japan. Emerg Infect Dis 26 : 2157-2161, 2020
 
20) Tsukamoto T, Nakajima N, Sakurai A, et al : Lung pathology of mutually exclusive co-infection with SARS-CoV-2 and Streptococcus pneumoniae. Emerg Infect Dis 27 : 919-923, 2021
PubMed
21) Nakamura Y, Katano H, Nakajima N, et al : SARS-CoV-2 is localized in cardiomyocytes : a postmortem biopsy case. Int J Infect Dis 111 : 43-46, 2021
PubMed
22) Hai le T, Thach HN, Tuan TA, et al : Adenovirus type 7 pneumonia in children who died from measles-associated pneumonia, Hanoi, Vietnam, 2014. Emerg Infect Dis 22 : 687-90, 2016
PubMed
P.365 掲載の参考文献
1) 吉田幸雄 : 図説 人体寄生虫学, 改訂10版, 南山堂, 2021
 
2) 上村清, 木村英作, 金子明他 : 寄生虫学テキスト, 第4版, 文光堂, 2019
 
3) 堤寛 : 感染症病理アトラス, 文光堂, 2000
 
4) Araya J, Kawabata Y, Tomochi N, et al : Allergic inflammatory reaction is involved in necrosis of human pulmonary dirofilariasis. Histopathology 51 : 484-490, 2007
 
5) 新実岳, 佐藤滋樹, 前田弘義他 : 非結核性抗酸菌症と鑑別を要した犬糸状虫症の1例. 日呼吸会誌 44 : 394-398, 2006
 
6) Nash G, Kerschmann RL, Herndier B, et al : The pathological manifestations of pulmonary toxoplasmosis in the acquired immunodeficiency syndrome. Hum Pathol 25 : 652-658, 1994.
PubMed
7) 宮川倫子, 望月吉郎, 中原保治他 : アメーバ性膿瘍の2例. 感染症学雑誌 84 : 464-468, 2010
 
8) 佐藤勝巳, 柴田茂雄, 佐藤良二他 : 多房性エヒノコッカス症の1解剖例. 札幌医誌 8 : 327-331, 1955
 
P.371 掲載の参考文献
1) Mandell LA, Niederman MS : Aspiration pneumonia. N Engl J Med 380 : 651-663, 2019
PubMed
2) Dickson RP, Erb-Downward JR, Huffnagle GB : The role of the bacterial microbiome in lung disease. Expert Rev Respir Med 7 : 245-257, 2013
PubMed
3) Marik PE : Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344 : 665-671, 2001
PubMed
4) Vilar J, Domingo ML, Soto C, et al : Radiology of bacterial pneumonia. Eur J Radiol 51 : 102-113, 2004
PubMed
5) Prather AD, Smith TR, Poletto DM, et al : Aspiration-related lung diseases. J Thorac Imaging 29 : 304-309, 2014
PubMed
6) Komiya K, Ishii H, Umeki K, et al : Computed tomography findings of aspiration pneumonia in 53 patients. Geriatr Gerontol Int 13 : 580-585, 2013
PubMed
7) Segal LN, Rom WN, Weiden MD : Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs. Ann Am Thorac Soc 11 : 108-116, 2014
PubMed
8) Dickson RP, Erb-Downward JR, Martinez FJ, et al : The microbiome and the respiratory tract. Annu Rev Physiol 78 : 481-504, 2016
PubMed
9) Huffnagle GB, Dickson RP, Lukacs NW : The respiratory tract microbiome and lung inflammation : a two-way street. Mucosal Immunol 10 : 299-306, 2017
PubMed
10) Wu BG, Segal LN : The lung microbiome and its role in pneumonia. Clin Chest Med 39 : 677-689, 2018
PubMed
P.374 掲載の参考文献
1) Homma S, Ebina M, Kuwano K, et al : Intractable diffuse pulmonary diseases : Manual for diagnosis and treatment. Respir Investig 59 : 8-33, 2021
PubMed
2) Ferreira Francisco FA, Pereira e Silva JL, Hochhegger B, et al : Pulmonary alveolar microlithiasis. State-of-the-art review. Respir Med 107 : 1-9, 2013
PubMed
3) Saito A, McCormack FX : Pulmonary alveolar microlithiasis. Clin Chest Med 37 : 441-448, 2016
PubMed
4) Bendstrup E, Jonsson ALM. Pulmonary alveolar microlithiasis : no longer in the stone age. ERJ Open Research 6 : 00289-2020, 2020
PubMed
5) Castellana G, Castellana G, Gentile M, et al : Pulmonary alveolar microlithiasis : review of the 1022 cases reported worldwide. Eur Respir Rev 24 : 607-620, 2015
PubMed
6) Huqun, Izumi S, Miyazawa H, et al : Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Resp Crit Care 175 : 263-268, 2007
 
7) Tachibana T, Hagiwara K, Johkoh T : Pulmonary alveolar microlithiasis : review and management. Curr Opin Pulm Med 15 : 486-490, 2009
PubMed
8) Kosciuk P, Meyer C, Wikenheiser-Brokamp KA, et al : Pulmonary alveolar microlithiasis. Eur Respir Rev 29 : 200024, 2020
 
9) Whitsett JA, Wert SE, Weaver TE : Diseases of pulmonary surfactant homeostasis. Annu Rev Pathol 10 : 371-393, 2015
PubMed
P.376 掲載の参考文献
1) 森本泰夫, 他 : 歯科技工士の職場における労働衛生管理. Ann Jpn Prosthodont Soc 12 : 227-233, 2020
 
2) Okamoto M, et al : Dental technicians' pneumoconiosis. Intern Med 15 : 56, 2017
 
3) 飴嶋慎吾, 他 : インジウム肺の1例. びまん性肺疾患研究会編 : びまん性肺疾患の臨床, 第4版, 金芳堂, 2012, pp526-529
 
4) 野上裕子, 他 : インジウム吸入による肺障害について. 日呼吸会誌 46 : 60-64, 2008
Medical*Online
5) 田口治, 他 : インジウム肺の3例. 日呼吸会誌 44 : 532-536, 2006
Medical*Online
6) Cummings KJ, et al : Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 181 : 458-464, 2009
PubMed
P.381 掲載の参考文献
1) Lara JF, Catroppo JF, Kim DU, et al : Dendriform pulmonary ossification, a form of diffuse pulmonary ossification : report of a 26-year autopsy experience. Arch Pathol Lab Med 129 : 348-353, 2005
PubMed
2) Egashira R, Jacob J, Kokosi MA, et al : Diffuse pulmonary ossification in fibrosing interstitial lung diseases : prevalence and associations. Radiology 284 : 255-263, 2017
PubMed
3) Konoglou M, Zarogoulidis P, Baliaka A, et al : Lung ossification : an orphan disease. J Thorac Dis 5 : 101-104, 2013
PubMed
4) Tseung J, Duflou J : Diffuse pulmonary ossification : an uncommon incidental autopsy finding. Pathology 38 : 45-48, 2006
PubMed
5) Fernandez Crisosto CA, Quercia Arias O, Bustamante N, et al : Diffuse pulmonary ossification associated with idiopathic pulmonary fibrosis. Arch Bronconeumol 40 : 595-598, 2004
PubMed
6) 岡輝明 : 肺骨化症pulmonary ossification. 『呼吸』eレポート 3 : 144-155, 2020
 
7) Peros-Golubicic T, Tekavec-Trkanjec J : Diffuse pulmonary ossification : an unusual interstitial lung disease. Curr Opin Pulm Med 14 : 488-492, 2008
PubMed
8) Kanne JP, Godwin JD, Takasugi JE, et al : Diffuse pulmonary ossification. J Thorac Imaging 19 : 98-102, 2004
 
9) Gao Y, Egan AM, Moua T : Dendriform pulmonary ossification complicated by recurrent spontaneous pneumothorax : Two case reports and a review of the literature. Respir Med Case Rep 30 : 101067, 2020
 
10) Kato T, Ishikawa K, Kadoya M, et al : Spontaneous pneumothorax in a patient with dendriform pulmonary ossification : report of a case. Surg Today 42 : 903-908, 2012
 
11) Wilson WR, Sasaki R, Johnson CA : Disseminated nodular pulmonary ossification in patients with mitral stenosis. Circulation 19 : 323-331, 1959
 
12) Galloway RW, Epstein EJ, Coulshed N : Pulmonary ossfic nodules in mitral value disease. Br Heart J 23 : 297-307, 1961
PubMed
13) Roriz D, Abreu I, Marques C, et al : Diffuse pulmonary ossification : A case report. Eur J Radiol Open 3 : 46-48, 2016
PubMed
14) Kawabata Y, Watanabe A, Yamaguchi S, et al : Pleuropulmonary pathology of vascular Ehlers-Danlos syndrome : spontaneous laceration, haematoma and fibrous nodules. Histopathology 56 : 944-950, 2010
PubMed
15) Battal B, Kocaoglu M, Ors F, et al : Massive pulmonary ossification due to recurrent aspiration pneumonia. Diagn Interv Radiol 15 : 212-214, 2009
PubMed
16) 栃井祥子, 根木隆浩, 栃井大輔他 : 胸腔鏡下肺生検により診断された特発性樹枝状肺骨化症の1例. 日本呼吸器外科学会雑誌 34 : 704-710, 2020
 
17) 小野健太郎, 竹田知史, 藤並舞他 : 胸腔鏡下肺生検術で診断し, 12年間の経過を観察しえた特発性樹枝状肺骨形成の1例. 日本呼吸器学会誌 2 : 264-268, 2013
Medical*Online
18) Ahari JE, Delaney M : Dendriform pulmonary ossification : a clinical diagnosis with 14 year follow-up. Chest 132 : 701A, 2007
 
19) Matsuo H, Handa T, Tsuchiya M, et al : Progressive restrictive ventilatory impairment in idiopathic diffuse pulmonary ossification. Intern Med 57 : 1631-1636, 2018
PubMed
20) Carney JM, Mammarappallil JG, Sporn TA, et al : Dendriform pulmonary ossification leading to bilateral lung transplant : a case report. Virchows Arch 473 : 379-383, 2018
PubMed
21) Yamagishi T, Fujimoto N, Miyamoto Y, et al : The rapid appearance and disappearance of dendriform pulmonary ossification after diffuse alveolar hemorrhage. Am J Respir Crit Care Med 193 : 333-334, 2016
PubMed
22) Fried ED, Godwin TA : Extensive diffuse pulmonary ossification. Chest 102 : 1614-1615, 1992
PubMed
23) Kinoshita Y, Mizuguchi I, Hidaka K, et al : Familial diffuse pulmonary ossification : A possible genetic disorder. Respir Investig 55 : 79-82, 2017
PubMed
24) Azuma A, Miyamoto H, Enomoto T, et al : Familial clustering of dendriform pulmonary ossification. Sarcoidosis Vasc Diffuse Lung Dis 20 : 152-154, 2003
PubMed
25) Gruden JF, Green DB, Legasto AC, et al : Dendriform pulmonary ossification in the absence of usual interstitial pneumonia : CT features and possible association with recurrent acid aspiration. AJR Am J Roentgenol 209 : 1209-1215, 2017
PubMed
26) 西谷憲三, 田尻さくら子, 佐藤雅子他 : 胸腔鏡下肺生検で診断された樹枝状型びまん性肺骨形成の1例. 日本内科学会雑誌 108 : 778-783, 2019
 
27) Marchiori E, Souza AS, Franquet T, et al : Diffuse highattenuation pulmonary abnormalities : a pattern-oriented diagnostic approach on high-resolution CT. AJR Am J Roentgenol 184 : 273-282, 2005
PubMed
28) Kim TS, Han J, Chung MP, et al : Disseminated dendriform pulmonary ossification associated with usual interstitial pneumonia : incidence and thin-section CT-pathologic correlation. Eur Radiol 15 : 1581-1585, 2005
PubMed
29) Seo JB, Im JG, Goo JM, et al : Atypical pulmonary metastases : spectrum of radiologic findings. Radiographics 21 : 403-417, 2001
PubMed
30) Sutthatarn P, Morin CE, Gartrell J, et al : Bilateral diffuse nodular pulmonary ossification mimicking metastatic disease in a patient with fibrolamellar hepatocellular carcinoma. Children (Basel) 8 : 226, 2021
 
31) Jamjoom L, Meziane M, Renapurkar RD : Dendriform pulmonary ossification : Report of two cases. Indian J Radiol Imaging 23 : 15-18, 2013
PubMed
32) Si X, Jin Y, Yang L : Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. Int J Oral Maxillofac Surg 27 : 310-314, 1998
PubMed
33) Chan ED, Morales DV, Welsh CH, et al : Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 165 : 1654-1669, 2002
PubMed
34) Whitaker W, Black A, Warrack AJ : Pulmonary ossification in patients with mitral stenosis. J Fac Radiol 7 : 29-34, 1955
PubMed
35) Fleming HA, Robinson CL : Pulmonary ossification with cardiac calcification in mitral valve disease. Br Heart J 19 : 532-538, 1957
 
P.385 掲載の参考文献
1) Hermansky P, Pudlak P : Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow : report of two cases with histochemical studies. Blood 14 : 162-169, 1959
 
2) Davies BH, Tuddenham EGD : Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome. Q J Med 45 : 219-232, 1976
 
3) Hermansky-Pudlak症候群合併間質性肺炎. 日本呼吸器学会監修, 厚生労働科学研究費補助金難治性疾患政策研究事業「びまん性肺疾患に関する調査研究」班 難治性びまん性肺疾患診療の手引き作成委員会編 : 難治性びまん性肺疾患診療の手引き, 南江堂, 2017, pp72-98
 
4) Yokoyama T, Gochuico BR : Hermansky-Pudlak syndrome pulmonary fibrosis : a rare inherited interstitial lung disease. Eur Respir Rev 30 : 200193, 2021
PubMed
5) Nakatani Y, Nakamura N, Sano J, et al : Interstitial pneumonia in Hermansky-Pudlak syndrome : significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 437 : 304-313, 2000
PubMed
6) Mahavadi P, Korfei M, Henneke I, et al : Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia. Am J Respir Crit Care Med 182 : 207-219, 2010
PubMed
7) Osanai K : Rab38 mutation and the lung phenotype. Review. Int J Mol Sci 19 : 2203, 2018
 
8) Zhang L, Yu K, Robert KW, et al : Rab38 targets to lamellar bodies and normalizes their sizes in lung alveolar type II epithelial cells. Am J Physiol Lung Cell Mol Physiol 301 : 461-477, 2011
 
9) 田中健介, 山田嘉仁 : Hermansky-Pudlak症候群. 呼吸器内科 37 : 117-123, 2020
 
10) 中谷行雄, 山中正二, 唐小燕 他 : Hermansky-Pudlak症候群の肺病理と病態. 病理と臨床24 : 913-920, 2006
 
P.390 掲載の参考文献
1) Estrada-Veras JI, O'Brien KJ, Boyd LC, et al : The clinical spectrum of Erdheim-Chester disease : an observational cohort study. Blood Advances 1 : 357-366, 2017
 
2) Swerdlow SH, Campo E, Pileri SA, et al : The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127 : 2375-2390, 2016
PubMed
3) Emile J-F, Abla O, Fraitag S, et al : Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127 : 2672-2681, 2016
PubMed
4) Diamond EL, Dagna L, Hyman DM, et al : Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 124 : 483-492, 2014
PubMed
5) Ozkaya N, Rosenblum MK, Durham BH, et al : The histopathology of Erdheim-Chester disease : a comprehensive review of a molecularly characterized cohort. Modern Pathology 31 : 581-597, 2018
PubMed
6) Allen CE, Parsons DW : Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders. Hematology 2015 : 559-564, 2015
PubMed
7) Hervier B, Haroche J, Arnaud L, et al : Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood 124 : 1119-1126, 2014
 
8) Roeser A, Cohen-Aubart F, Breillat P, et al : Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors. Haematologica 104 : e502-e505, 2019
PubMed
9) Papo M, Diamond EL, Cohen-Aubart F, et al : High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. Blood 130 : 1007-1013, 2017
PubMed
10) Cohen-Aubart F, Emile J-F, Carrat F, et al : Phenotypes and survival in Erdheim-Chester disease : Results from a 165-patient cohort. Am J Hematol 93 : E114-E117, 2018
PubMed
11) Arnaud L, Hervier B, Neel A, et al : CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease : a multicenter survival analysis of 53 patients. Blood 117 : 2778-2782, 2011
 
12) Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al : Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 75 : 157-169, 1996
PubMed
13) Kumar P, Singh A, Gamanagatti S, et al : Imaging findings in Erdheim-Chester disease : what every radiologist needs to know. Pol J Radiol 83 : 54-62, 2018
 
14) Wittenberg KH, Swensen SJ, Myers JL : Pulmonary involvement with Erdheim-Chester disease. AJR Am J Roentgenol 174 : 1327-1331, 2000
PubMed
15) WHO Classification of Tumours : Thoracic Tumours (5th ed), 2021
 
P.398 掲載の参考文献
1) Malfait F, Francomano C, Byers P, et al : The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet Part C Semin Med Genet 175 : 8-26, 2017
PubMed
2) Byers PH, Belmont J, Black J, et al : Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome. Am J Med Genet Part C Semin Med Genet 175 : 40-47, 2017
PubMed
3) Legrand A, Devriese M, Dupuis-Girod S, et al : Frequency of de novo variants and parental mosaicism in vascular Ehlers-Danlos syndrome. Genet Med 21 : 1568-1575, 2019
PubMed
4) Shalhub S, Byers PH, Hicks KL : A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis. J Vasc Surg 71 : 149-157, 2020
PubMed
5) Shalhub S, Neptune E, Sanchez DE, et al : Spontaneous pneumothorax and hemothorax frequently precede the arterial and intestinal complications of vascular Ehlers-Danlos syndrome. Am J Med Genet A 179 : 797-802, 2019
PubMed
6) Kawabata Y, Watanabe A, Yamaguchi S, et al : Pleuropulmonary pathology of vascular Ehlers-Danlos syndrome : spontaneous laceration, haematoma and fibrous nodules. Histopathology 56 : 944-950, 2010
PubMed
7) Shields LB, Rolf CM, Davis GJ, et al : Sudden and unexpected death in three cases of Ehlers-Danlos syndrome type IV. J Forensic Sci 55 : 1641-1645, 2010
PubMed
8) Berezowska S, Christe A, Bartholdi D, et al : Pulmonary fibrous nodule with ossifications may indicate vascular Ehlers-Danlos syndrome with missense mutation in COL3A1. Am J Respir Crit Care Med 197 : 661-662, 2018
PubMed
9) Matsushita A, Takayanagi N, Ishiguro T, et al : A case of Ehlers-Danlos syndrome suspected from pulmonary hematoma due to disruption of the lung. Nihon Kokyuki Gakkai Zasshi 47 : 704-710, 2009
PubMed
10) Corrin B, Simpson CG, Fisher C : Fibrous pseudotumours and cyst formation in the lungs in Ehlers-Danlos syndrome. Histopathology 17 : 478-479, 1990
PubMed
11) Watanabe A, Kawabata Y, Okada O, et al : Ehlers-Danlos syndrome type IV with few extrathoracic findings : a newly recognized point mutation in the COL3A1 gene. Eur Respir J 19 : 195-198, 2002
 
12) 松下文, 高柳昇, 石黒卓, 他 : 肺裂傷に伴う肺血腫が診断契機となったEhlers-Danlos症候群の1例. 日呼吸会誌 47 : 704-710, 2009
Medical*Online
13) 河端美則, 渡辺哲 : 血管型Ehlers-Danlos症候群に見られる胸膜肺病変の病理. 日胸臨 70 : 345-356, 2011
Medical*Online
14) Salik I, Rawla P. Salik I, et al : Marfan syndrome. in StatPearls [ Internet], StatPearls Publishing, 2020
 
15) Kolonics-Farkas AM, Agg B, Benke K, et al : Lung function changes are more common in Marfan patients who need major thoracic surgery. Lung 197 : 465-472, 2019
PubMed
16) Dyhdalo K, Farver C : Pulmonary histologic changes in Marfan syndrome : a case series and literature review. Am J Clin Pathol 136 : 857-863, 2011
PubMed
17) Hwang HS, Yi CA, Yoo H, et al : The prevalence of bronchiectasis in patients with Marfan syndrome. Int J Tuberc Lung Dis 18 : 995-997, 2014
PubMed
18) Wood JR, Bellamy D, Child AH, et al : Pulmonary disease in patients with Marfan syndrome. Thorax 39 : 780-784, 1984
PubMed
19) 斎藤博之, 飯島克順, 檀原高他 : 気管支拡張症で発症し多発性気腫性嚢胞・呼吸不全へ進展したMarfan症候群の1剖検例. 日胸疾会誌 30 : 1315-1321, 1992
 
20) Ishii H, Shima R, Kinoshita Y, et al : Marfan syndrome presenting with diffuse emphysematous change of the lung. BMJ Case Rep 2018 : bcr2017224056, 2018
PubMed
P.403 掲載の参考文献
1) Christie JD, Edwards LB, Kucheryavaya AY, et al : International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation : 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 31 : 1073-1086, 2012
PubMed
2) Stewart S, Fishbein MC, Snell GI, et al : Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26 : 1229-1242, 2007
 
3) Roden AC, Aisner DL, Allen TC, et al : Diagnosis of acute cellular rejection and antibody-mediated rejection on lung transplant biopsies : A perspective from members of the pulmonary pathology Society. Arch Pathol Lab Med 141 : 437-444, 2017
PubMed
4) Bery AI, Hachem RR. Antibody-mediated rejection after lung transplantation. Ann Transl Med 8 : 411, 2020
PubMed
5) Levine DJ, Glanville AR, Aboyoun C, et al : Antibody-mediated rejection of the lung : A consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 35 : 397-406, 2016
 
P.410 掲載の参考文献
1) 日本造血細胞移植学会 : 造血細胞移植ガイドライン GVHD, 第4版, 2018 (https://www.jshct.com/uploads/files/guideline/01_02_gvhd_ver04.pdf)
 
2) Zeiser R, Blazar BR : Acute graft-versus-host disease-Biologic process, prevention, and therapy. N Engl J Med 377 : 2167-2179, 2017
PubMed
3) Klein OR, Cooke KR : Idiopathic pneumonia syndrome following hematopoietic stem cell transplantation. J Pediatr Intensive Care 3 : 147-157, 2014
 
4) Panoskaltsis-Mortari A, Griese M, Madtes DK, et al : An official American Thoracic Society research statement : noninfectious lung injury after hematopoietic stem cell transplantation : idiopathic pneumonia syndrome. Am J Respir Crit Care Med 183 : 1262-1279, 2011
PubMed
5) Jagasia MH, Greinix HT, Arora M, et al : National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease : I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21 : 389-401, 2015
 
6) Bergeron A : Late-onset noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Clin Chest Med 38 : 249-262, 2017
PubMed
7) von der Thusen JH, Hansell DM, Tominaga M, et al : Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol 24 : 1633-1639, 2011
PubMed
8) Mariani F, Gatti B, Rocca A, et al : Pleuroparenchymal fibroelastosis : the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients. Diagn Interv Radiol 22 : 400-406, 2016
PubMed
9) Barker AF, Bergeron A, Rom WN, et al : Obliterative bronchiolitis. N Engl J Med 370 : 1820-1828, 2014
PubMed
10) Yousem SA : The histological spectrum of pulmonary graftversus-host disease in bone marrow transplant recipients. Hum Pathol 26 : 668-675, 1995
 
11) Kambham N, Higgins JP, Sundram U, et al : Hematopoietic stem cell transplantation : graft versus host disease and pathology of gastrointestinal tract, liver, and lung. Adv Anat Pathol 21 : 301-320, 2014
PubMed
12) Xu L, Drachenberg C, Tavora F, et al : Histologic findings in lung biopsies in patients with suspected graft-versus-host disease. Hum Pathol 44 : 1233-1240, 2013
PubMed
13) Nassereddine S, Rafei H, Elbahesh E, et al : Acute graft versus host disease : A comprehensive review. Anticancer Res 37 : 1547-1555, 2017
PubMed
14) Seo S, Renaud C, Kuypers JM, et al : Idiopathic pneumonia syndrome after hematopoietic cell transplantation : evidence of occult infectious etiologies. Blood 125 : 3789-3797, 2015
PubMed
P.414 掲載の参考文献
1) Ch'In KY, Tang MY : Congenital adenomatoid malformation of one lobe of a lung with general anasarca. Arch Pathol (Chic) 48 : 221-229, 1949
 
2) Stocker JT, Madewell JE, Drake RM : Congenital cystic adenomatoid malformation of the lung. Classification and morphologic spectrum. Hum Pathol 8 : 155-171, 1977
PubMed
3) Stocker J : Congenital pulmonary airway malformation : A new name for and an expanded classification of congenital cystic adenomatoid malformation of the lung. Symposium 24 : Non-neoplastic lung disease. Histopathology 41 (Suppl 2) : 424-430, 2002
 
4) Rutledge JC, Jensen P : Acinar dysplasia : a new form of pulmonary maldevelopment. Hum Pathol 17 : 1290-1293, 1986
PubMed
5) Gillespie LM, Fenton AC, Wright C : Acinar dysplasia : a rare cause of neonatal respiratory failure. Acta Paediatr 93 : 712-713, 2004
PubMed
6) Karolak JA, Vincent M, Deutsch G, et al : Complex compound inheritance of lethal lung developmental disorders due to disruption of the TBX-FGF pathway. Am J Hum Genet 104 : 213-228, 2019
PubMed
7) Dehner LP, Stocker JT, Mani H, et al : Congenital Pulmonary Airway Malformation in the Respiratory Tract (4th ed), Philadelphia : Wolters Kluwer, 2016
 
8) Guo H, Cajaiba MM, Borys D, et al : Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation. Hum Pathol 38 : 1772-1778, 2007
 
9) Lantuejoul S, Nicholson AG, Sartori G, et al : Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors. Am J Surg Pathol 31 : 961-969, 2007
PubMed
10) Fraggetta F, Davenport M, Magro G, et al : Striated muscle cells in non-neoplastic lung tissue : a clinicopathologic study. Hum Pathol 31 : 1477-1481, 2000
 
11) Riedlinger WF, Vargas SO, Jennings RW, et al : Bronchial atresia is common to extralobar sequestration, intralobar sequestration, congenital cystic adenomatoid malformation, and lobar emphysema. Pediatr Dev Pathol 9 : 361-373, 2006
PubMed
12) Langston C : New concepts in the pathology of congenital lung malformations. Semin Pediatr Surg 12 : 17-37, 2003
PubMed
13) Robertson JC, Jorcyk CL, Oxford JT : DICER1 syndrome : DICER1 mutations in rare cancers. Cancers (Basel) 10 : 143, 2018
 
14) Schultz KAP, Williams GM, Kamihara J, et al : DICER1 and associated conditions : identification of at-risk individuals and recommended surveillance strategies. Clin Cancer Res 24 : 2251-2261, 2018
PubMed
15) Feinberg A, Hall NJ, Williams GM, et al : Can congenital pulmonary airway malformation be distinguished from Type I pleuropulmonary blastoma based on clinical and radiological features? J Pediatr Surg 51 : 33-37, 2016
PubMed
P.420 掲載の参考文献
1) Zhang N, Zeng Q, Chen C, et al : Distribution, diagnosis, and treatment of pulmonary sequestration : Report of 208 cases. J Pediatr Surg 54 : 1286-1292, 2019
 
2) Savic B, Birtel FJ, Tholen W, et al : Lung sequestration : report of seven cases and review of 540 published cases. Thorax 34 : 96-101, 1979
PubMed
3) Conran RM, Stocker JT : Extralobar sequestration with frequently associated congenital cystic adenomatoid malformation, type 2 : report of 50 cases. Pediatr Dev Pathol 2 : 454-463, 1999
PubMed
4) Stocker JT, Kagan-Hallet K : Extralobar pulmonary sequestration : analysis of 15 cases. Am J Clin Pathol 72 : 917-925, 1979
PubMed
5) 石田治雄, 初鹿野浩, 林奐 : 小児肺葉内肺分画症20例の検討-分画肺内の気管支構造より. 日胸外会誌 40 : 957-968, 1992
 
6) Fraggetta F, Davenport M, Magro G, et al : Striated muscle cells in non-neoplastic lung tissue : a clinicopathologic study. Hum Pathol 31 : 1477-1481, 2000
 
7) Stocker JT, Malczak HT : A study of pulmonary ligament arteries. Relationship to intralobar pulmonary sequestration. Chest 86 : 611-615, 1984
PubMed
8) Walford N, Htun K, Chen J, et al : Intralobar sequestration of the lung is a congenital anomaly : anatomopathological analysis of four cases diagnosed in fetal life. Pediatr Dev Pathol 6 : 314-321, 2003
PubMed
9) Mehta RP, Faquin WC, Cunningham MJ : Cervical bronchogenic cysts : a consideration in the differential diagnosis of pediatric cervical cystic masses. Int J Pediatr Otorhinolaryngol 68 : 563-568, 2004
PubMed
10) Sauvat F, Fusaro F, Jaubert F, et al : Paraesophageal bronchogenic cyst : first case reports in pediatric. Pediatr Surg Int 22 : 849-851, 2006
PubMed
11) Black TL, Fernandes ET, Wrenn EL Jr, et al : Extralobar pulmonary sequestration and mediastinal bronchogenic cyst. J Pediatr Surg 23 : 999-1001, 1988
PubMed
12) 西島栄, 東本恭, 連利他 : 最近の小児呼吸器外科の動向-Bronchopulmonary-foregut malformation (BPFM) の発生機構とその臨床. 小児外科 25 : 1253-1260, 1993
 
P.426 掲載の参考文献
1) Hislop AA : Airway and blood vessel interaction during lung development. J Anat 201 : 325-334, 2002
PubMed
2) Schittny JC : Development of the lung. Cell Tissue Res 367 : 427-444, 2017
PubMed
3) Davis E, Potter EL : Intrauterine respiration of the human fetus. JAMA 131 : 1194-1200, 1946
 
4) Katz C, Bentur L, Elias N : Clinical implication of lung fluid balance in the perinatal period. J Perinatol 31 : 230-235, 2011
PubMed
5) Haller JA, Tepas III JJ, White JJ, et al : The natural history of bronchial atresia. J Thorac Cardiovasc Surg 79 : 868-872, 1980
 
6) Simon G, Reid L : Atresia of an apical bronchus of the left upper lobe-report of three cases. Brit J Dis Chest 57 : 126-132, 1963
PubMed
7) Alamo L, Vial Y, Gengler C, et al : Imaging findings of bronchial atresia in fetuses, neonates and infants. Pediatr Radiol 46 : 383-390, 2016
PubMed
8) Jederlinic PJ, Sicilian LS, Baigelman W, et al : Congenital bronchial atresia. Medicine (Baltimore) 66 : 73-83, 1987
PubMed
9) Morikawa N, Kuroda T, Honna T, et al : Congenital bronchial atresia in infants and children. J Pediat Surg 40 : 1822-1826, 2005
 
10) Watanabe T, Ohno M, Tahara K, et al : An investigation on clinical differences between congenital pulmonary airway malformation and bronchial atresia. J Pediat Surg 53 : 2390-2393, 2018
PubMed
11) Griscom NT, Harris GBC, Wohl MEB, et al : Fluid-filled lung due to airway obstruction in the newborn. Pediatrics 43 : 383-390, 1969
 
12) 益田貞彦 : Bronchial atresiaの6例. 日胸 48 : 99-107, 1989
 
13) 山下英秋 : X線読影に必要な肺の解剖. 藤田真之介他編, 日本結核全書 第4巻 第1 (X線学的診断 第1), 金原出版, 1956, p1-64
 
14) Stocker J : Congenital pulmonary airway malformation : a new name for and an expanded classification of congenital adenomatoid malformation of the lung. Histopathology 41 (Supple 2) : 424-430, 2002
 
15) Imai Y, Mark EJ : Cystic adenomatoid change is common to various forms of cystic lung diseases of children. Arch Pathol Lab Med 126 : 934-940, 2002
PubMed
16) Peranteau WH, Merchant AM, Hedrick HL, et al : Prenatal course and postnatal management of peripheral bronchial atresia : association with congenital cystic adenomatoid malformation of the lung. Fetal Diagn Ther 24 : 190-196, 2008
PubMed
17) Langman C : New concept in the pathology of congenital lung malformation. Semin Pediatr Surg 12 : 17-37, 2003
 
18) Gerle RD, Jaretzki A 3rd, Ashley CA, et al : Congenital bronchopulmonary-foregut malformation. Pulmonary sequestration communicating with the gastrointestinal tract. N Engl J Med 278 : 1413-1419, 1968
PubMed
P.428 掲載の参考文献
1) 山下素弘, 清水信義 : 肺動静脈瘻. 別冊日本臨牀領域別症候群 13 : 311-313, 1996
 
2) 巽浩一郎 : 肺動静脈瘻. 呼吸 27 : 169-172, 2008
Medical*Online
3) Cottin V, Dupuis-Girod S, Lesca G, et al : Pulmoanry vascular manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler disease). Respiration 74 : 361-378, 2007
 
4) Sharathkumar AA, Shapiro A : Hereditary haemorrhagic telangiectasia. Haemophilia 14 : 1269-1280, 2008
PubMed
5) Ishikawa T, Pollak S, Pflugradt R, et al : Pulmonary arteriovenous malformation causing sudden death due to spontaneous hemothorax. Int J Legal Med 124 : 459-465, 2010
PubMed
6) White RI Jr, Pollak JS, Wirth JA : Pulmonary arteriovenous malformations : diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 7 : 787-804, 1996
PubMed

書評

最近チェックした商品履歴

Loading...